US20120091813A1 - Method and apparatus for predicting end of battery life - Google Patents
Method and apparatus for predicting end of battery life Download PDFInfo
- Publication number
- US20120091813A1 US20120091813A1 US13/332,249 US201113332249A US2012091813A1 US 20120091813 A1 US20120091813 A1 US 20120091813A1 US 201113332249 A US201113332249 A US 201113332249A US 2012091813 A1 US2012091813 A1 US 2012091813A1
- Authority
- US
- United States
- Prior art keywords
- battery
- voltage
- main battery
- backup
- main
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
- G06F1/26—Power supply means, e.g. regulation thereof
- G06F1/30—Means for acting in the event of power-supply failure or interruption, e.g. power-supply fluctuations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
- H02J7/34—Parallel operation in networks using both storage and other dc sources, e.g. providing buffering
- H02J7/342—The other DC source being a battery actively interacting with the first one, i.e. battery to battery charging
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J9/00—Circuit arrangements for emergency or stand-by power supply, e.g. for emergency lighting
- H02J9/04—Circuit arrangements for emergency or stand-by power supply, e.g. for emergency lighting in which the distribution system is disconnected from the normal source and connected to a standby source
- H02J9/06—Circuit arrangements for emergency or stand-by power supply, e.g. for emergency lighting in which the distribution system is disconnected from the normal source and connected to a standby source with automatic change-over, e.g. UPS systems
- H02J9/061—Circuit arrangements for emergency or stand-by power supply, e.g. for emergency lighting in which the distribution system is disconnected from the normal source and connected to a standby source with automatic change-over, e.g. UPS systems for DC powered loads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/80—General characteristics of the apparatus voice-operated command
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/01—Remote controllers for specific apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J2310/00—The network for supplying or distributing electric power characterised by its spatial reach or by the load
- H02J2310/10—The network having a local or delimited stationary reach
- H02J2310/20—The network being internal to a load
- H02J2310/23—The load being a medical device, a medical implant, or a life supporting device
Definitions
- the field of the invention is the providing of power for portable electronic devices, such as insulin pumps, analyte sensor devices, portable phones, personal digital assistants, etc.
- the invention is directed to powering a portable electronic device for a known period of time after depletion of the main battery regardless of the type of battery that is installed in the portable electronic device.
- FIG. 1( a ) illustrates a voltage level over time provided by different types of batteries.
- the alkaline battery starts out at a high voltage, e.g., approximately 1.55 volts, and decreases over time.
- Line D represents a battery threshold voltage. This low battery threshold voltage represents a value at which the battery is determined to be providing a low voltage. Once this threshold is reached, a message will need to be transmitted to a display of the portable electronic device indicating that the battery is running low, and should be replaced.
- the voltage threshold may be around 1.16 or 1.08 volts.
- the alkaline battery can normally provide power to the portable electronic device for approximately twelve hours, assuming that the main battery life of the alkaline battery is 30 days. It should be noted that battery life is dependent on actual energy used by the device. Also, it also should be noted that due to the voltage threshold being around 1.1 volts, it is estimated that only two-thirds of the battery energy of the alkaline battery is utilized.
- a lithium battery is capable of providing a much higher initial voltage and sustaining the value of that voltage for a long period of time. However, as illustrated by line B in FIG. 1( a ), once the lithium battery becomes drained, the decrease in voltage value is rapid. If a lithium battery is being used in a portable electronic device, a user of the portable electronic device may have less than 30 minutes after receiving a low voltage message before the portable electronic device loses power. If the user is utilizing the portable electronic device for medical reasons, e.g., like an insulin pump, blood glucose sensor or meter, this may not provide the user with enough time to find a replacement battery.
- a rechargeable battery can be a good economic solution for an owner of a portable electronic device. Rather than buying a new set of batteries every week or every month, the user may utilize household current to charge up the battery after the battery has expended its energy. Many portable electronic devices cannot utilize rechargeable batteries because the initial voltage supplied by the battery is too low and sometimes is not greater than the low battery threshold voltage set for alkaline batteries.
- the rechargeable battery has characteristics similar to the alkaline battery in terms of how long it can power a device, but as illustrated by Line C in FIG. 1( a ), the initial voltage supplied by the rechargeable battery is lower than the initial voltage supplied by the alkaline battery.
- some initial voltages for rechargeable batteries may be lower than the low battery threshold voltage for the portable electronic device, as is mentioned above, and the portable electronic device may generate a message indicating that the rechargeable battery cannot be utilized. This is also true in regards to partially drained batteries, which may have low initial voltage readings.
- the effective voltage of any of these batteries can be affected by the environment in which the battery is stored or utilized. For example, a temperature change in the environment in which the battery is located, can reduce the effective voltage provided by the battery. Also, subjecting the battery to vibration can result in a lowering of the effective voltage generated by the battery. This results in the battery providing a voltage reading that is lower than the low battery threshold and thus the portable electronic device may be unable to utilize the batteries subjected to changes in temperature as well as vibration.
- Many current portable electronic devices that utilize a DC power source also include a backup battery system that provides a limited amount of functionality for the portable electronic device until the DC power source is replaced or recharged.
- the backup battery may provide enough energy to operate a run time clock for the portable electronic device and to save the contents of a memory, but does not provide power for full functionality of the portable electronic device.
- a method of providing backup power to a portable electronic device is provided.
- a battery level of a primary battery is monitored.
- a disconnect signal is generated to cause the primary battery to be disconnected if the battery level of the primary battery is below a low battery threshold.
- a connection signal is generated to couple a backup battery to power the portable electronic device if the battery level of the primary battery is below the low battery threshold.
- the backup battery provides power for operating the portable electronic device for a predetermined minimum time regardless of what type of battery is utilized in the portable electronic device.
- the portable electronic device detects whether the main battery has been inserted into the portable electronic device and a detection signal is transmitted to a controller if the main battery is detected. If the main battery has been detected, a voltage output from the main battery is coupled to a power converter. The converter provides an operating voltage to the controller after receiving the voltage from the main battery. The controller charges a backup battery utilizing a signal transmitted from the controller. The controller monitors the battery level of the backup battery to determine if the backup battery has been fully charged. The controller disables charging of the backup battery if the charging level of the backup battery has been exceeded, which represents that the backup battery is adequately charged.
- FIG. 1( a ) illustrates a voltage level over time provided by different types of batteries
- FIG. 1( b ) illustrates a front view of a controller device according to an embodiment of the invention
- FIG. 2 illustrates a front view of a blood glucose meter integrated into the controller device housing according to an embodiment of the present invention
- FIG. 3 is a front view of a blood glucose meter integrated into a controller device housing according to an embodiment of the present invention
- FIG. 4 is a front view of a blood glucose meter integrated into a controller device housing communicating with an infusion device according to an embodiment of the present invention
- FIG. 5 provides a block diagram of a RF communication system in the infusion device according to an embodiment of the present invention
- FIG. 6 a is a block diagram of a the controller device according to an embodiment of the present invention.
- FIG. 6 b is a block diagram of a controller device according to an embodiment of the invention.
- FIG. 7 is a block diagram of communication paths within the infusion system according to an embodiment of the present invention.
- FIG. 8 is a diagram of an electronics architecture according to an embodiment of the invention with a custom integrated circuit
- FIG. 9 illustrates a method to provide full functioning power to a portable electronic device after a main battery has reached a low voltage threshold according to an embodiment of the present invention.
- FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention.
- the controller device is a hand-held device separate from the therapy/diagnostic device, such as an infusion device, that allows the user to communicate with the therapy/diagnostic device without actually handling the device.
- therapy/diagnostic devices include electronic therapy devices and devices that receive diagnostic information from cardiac and other sensors.
- the controller device 5 includes a housing 3 adapted to be carried by the user and a communication system (not shown) contained in the housing 3 for transmitting a communication or command from the user to the infusion device.
- the controller device 5 may receive communications sent from the infusion device or other components of the infusion system, such as for example, a characteristic determining device.
- the controller device may include one or more user input devices 2 a and 2 b on the controller device housing 3 , such as keys, buttons, or the like, for the user to input data or commands.
- the controller device 5 includes a display 4 on the controller device housing 3 which simultaneously displays whatever information and/or graph is being displayed on the infusion device display at that moment.
- the display 4 allows a user to easily monitor and control what actions are taking place in, or being performed by, the infusion device.
- the controller device 5 may further include a backlight 1 in the controller device display 4 for easier viewing.
- the backlight may be adapted to be in one or more colors, which can be user selectable for personalized use.
- the backlight may be adapted to flash and/or turn to a color such as yellow or red when various alerts and alarms take place.
- the controller device 5 may include accessories such as hand straps 6 to provide convenient handling.
- the controller is sized smaller than 6 inches long by 4 inches wide by 1 inch thick.
- a characteristic determining device that senses and determines the concentration of an analyte of a patient, for example blood glucose (“BG”), and controls the infusion device according to the measurements, may be included in an infusion system with the controller device and the infusion device.
- the characteristic determining device includes a housing, a receptacle coupled to the housing for receiving and testing an analyte from the user to determine a concentration of the analyte in the user, a processor contained in the housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle, and a communication system contained in the housing and coupled to the processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user.
- the characteristic determining device may also include a lancing device coupled to the receptacle for obtaining the analyte from the user.
- the infusion device includes a housing adapted to be carried by the user, a drive mechanism contained in the housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user, a communication system contained in the housing for receiving the communication including the data indicative of the determined concentration of an analyte in the user from a characteristic determining device, and a processor contained in the housing and coupled to the communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device.
- the infusion device is sized smaller than 6 inches long by 4 inches wide by 1 inch thick.
- the infusion device may further include a bolus estimator used in conjunction with the processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated.
- the system may determine the concentration of one of any variety of analyte types including, but not limited to, oxygen, blood, temperature, lactase, pH, implantable, and the like.
- the infusion device may include a user input device, such as keys, buttons, or the like, for inputting an estimate of a material to be ingested by the user, and the bolus estimator may include the capability to calculate the estimated amount of fluid to be infused into the body of the user based upon the inputted estimate of the material to be ingested by the user.
- the infusion device may also include a memory for storing the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system.
- the characteristic determining device is a BG measurement device and may use samples from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like.
- other measurement devices may be utilized to determine the concentrations, levels, or quantities of other characteristics, analytes, or agents in the user, such as hormones, cholesterol, oxygen, pH, lactate, heart rate, respiratory rate, medication concentrations, viral loads (e.g., HIV), or the like.
- other fluids may be delivered to the user, such as medication other than insulin (e.g., HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, and anti-cancer treatments), chemicals, enzymes, antigens, hormones, vitamins, or the like.
- medication other than insulin e.g., HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, and anti-cancer treatments
- chemicals, enzymes, antigens, hormones, vitamins, or the like e.g., HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, and anti-cancer treatments
- enzymes e.g., antigens, hormones, vitamins, or the like.
- a bolus function may be set up as a Patient Controlled Analgesic (PCA) function for customized delivery or the user may press a preset bolus button several times.
- PCA Patient Controlled Analgesic
- the characteristic determining device is a BG meter that determines BG level and the infusion device is an insulin infusion pump.
- the BG meter communicates the measurement of BG to the infusion pump device to determine the amount of insulin for delivery to the user.
- the BG measurement device may be a continuous glucose measurement system, a hospital hemacue, an automated intermittent blood glucose measurement system, and the like, and/or the BG measurement device may use other methods for measuring the user's BG level, such as a sensor in contact with a body fluid, an optical sensor, a RF sensor, an enzymatic sensor, a fluorescent sensor, a blood sample placed in a receptacle, or the like.
- the BG measurement device may generally be of the type and/or include features disclosed in U.S. patent applications Ser. No. 09/377,472 filed Aug. 19, 1999 and entitled “Telemetered Characteristic Monitor System and Method of Using the Same,” Ser. No. 09/334,996 filed Jun. 17, 1999 and entitled “Characteristic Monitor with a Characteristic Meter and Method of Using the Same,” Ser. No. 09/487,423 filed Jan. 20, 2000 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” and Ser. No. 09/935,827 filed Aug. 23, 2001 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” which are herein incorporated by reference.
- PDA Personal Data Assistant
- Such BG measurement devices may be adapted to be carried by the user, for example, in the hand, on the body, in a clothing pocket, attached to clothing (e.g., using a clip, strap, adhesive, or fastener), and the like.
- the BG measurement device is sized smaller than 6 inches long by 4 inches wide by 1 inch thick.
- the BG meter may be integrated into the controller device housing, as shown in FIG. 2 , where the controller device housing 15 includes a BG meter receptacle 20 .
- the controller 10 includes a housing 15 adapted to be carried by the user, a BG meter receptacle 20 coupled to the housing 15 for receiving and testing BG level from the user to determine a concentration of the BG in the user.
- a BG test strip 25 that holds a use blood sample is inserted into the BG meter receptacle 20 for the testing by the controller device 10 .
- the controller device 10 may have a cartridge-like mechanism which loads and presents the strip for testing and then ejects it.
- the controller device 10 has a display 30 on the housing 15 to show information requested by the user or an instructed act that was undertaken by the infusion device, such as for example, determined concentration of blood glucose levels, BG trends or graphs, such as described and disclosed in U.S. patent application Ser. No. 10/624,177, entitled “System for Monitoring Physiological Characteristics,” which is herein incorporated by reference.
- the display 30 may further include a dedicated backlight 35 to facilitate viewing.
- the backlight 35 may be a user programmable multi-color backlight that additionally performs the function of a visual indicator by flashing colors appropriate to the level of an alert or alarm.
- the backlight 35 may also have variable intensity (automatic or manual) to preserve the battery power and improved viewing.
- the controller 10 includes a keypad 40 on which various input devices, such as keys, buttons, or the like, are located.
- the keypad buttons 45 a , 45 b , 45 c , and 45 d are used by the user to select options and/or input information.
- the power of the controller device and of the other various devices discussed herein may be provided from a battery.
- the battery may be a single use or a rechargeable battery. Where the battery is rechargeable, there may be a connector or other interface on a device to attach the device to an electrical outlet, docking station, portable recharger, or so forth to recharge the battery while in the device. It is also possible that a rechargeable battery may be removable from the device for recharging outside of the device, however, in some cases, the rechargeable battery may be sealed into the housing of the device to create a more water resistant or waterproof housing.
- the devices may be adapted to accommodate various battery types and shapes. In further embodiments, the devices may be adapted to accommodate more than one type of battery. For example, a device may be adapted to accommodate a rechargeable battery and, in the event of battery failure or other need, also adapted to accommodate a readily available battery, such as a AA battery, AAA battery, or coin cell battery.
- the controller device 110 includes a housing 115 adapted to be carried by the user, and a BG meter receptacle 120 coupled to the housing 115 for receiving and testing BG level from the user to determine a concentration of the BG in the user.
- a BG test strip 125 that holds a user's blood sample is inserted into the BG meter receptacle 120 for the testing by the controller device 110 .
- the controller device 110 has a display 130 on the housing 115 to show information requested by the user or an instructed act that was undertaken by the infusion device, such as for example, determined concentration of blood glucose levels, graphs of blood glucose level trends or fluid delivery information.
- the display 130 may include a dedicated backlight 135 to facilitate viewing.
- the controller device 110 includes a few input devices, such as keys, buttons, or the like, on the housing 115 .
- the housing buttons 145 a , 145 b , and 145 c are used by the user to select options and/or input information.
- FIG. 4 illustrates an embodiment of an infusion system that includes an infusion device 50 , and further includes a controller device integrated with a BG meter 10 , where both share one housing.
- the controller device 10 communicates to the infusion pump device 50 through a wireless method, for example RF signals.
- the controller device 10 senses and determines the concentration of BG level of a patient and controls the infusion device 50 according to the measurements. This substantially reduces, if not eliminates, calculations on the part of the patient.
- the infusion device 50 includes a housing 55 adapted to be carried by the user. On the housing 55 there is included a display 60 that, like the BG meter display 30 , shows information requested by the user or an instructed act that was undertaken by the infusion device 50 .
- the infusion device 50 may not include a display, but in that case there should be a suspend/resume input and an action input for safety reasons.
- the BG meter display 30 shows information according to communications sent to the controller device 10 from the infusion device 50 .
- the display 60 of the infusion device 50 may show substantially the same information as shown on the controller device display 30 .
- the two displays may mimic one another so that the user may choose to conveniently view the selected information from the controller device 10 rather than the infusion device 50 , which is usually attached to the user's body through the infusion set 75 .
- the infusion device 50 delivers fluid from within the housing 55 , through tubing 80 and into the infusion set 75 into the user's body at an infusion site.
- a keypad 65 with various input devices, such as the keypad buttons 70 a , 70 b , and 70 c illustrated in the figure.
- FIG. 5 provides a block diagram of the infusion device 150 .
- the infusion device 150 includes a drive mechanism 152 contained in the housing 172 and operatively coupled with a reservoir 154 containing the fluid for infusing the fluid into the body of the user, a communication system 156 contained in the housing 172 for receiving the communication from the controller device including data indicative of the determined concentration of the BG in the user from the BG meter, and a processor 158 contained in the housing 172 and coupled to the communication system 156 for processing the received communications and controlling the infusion device 150 .
- the fluid is delivered from the reservoir 154 through an outlet 168 in the housing 172 and into the user's body via the tubing 180 and infusion set 175 .
- the infusion device 150 may further include an indicator displayed on the display 160 to indicate when the estimated amount of fluid to be infused has been calculated. Additionally, the infusion device 150 may include one or more user input device(s), such as keys, buttons, and the like, for inputting an estimate of a material to be ingested by the user, and the estimated amount of fluid to be infused into the body of the user may be based upon this inputted estimate of material to be ingested. A bolus estimator may be used in conjunction with the infusion device processor for estimating the appropriate amount of fluid to be infused into the body of the user. There may be included a keypad 165 on which the one or more input device(s) are located. The infusion device 150 may also include a memory 166 for storing the data received by the infusion device communication system 156 from the controller device communication system.
- a speaker 164 is included to provide an alternative mode of communication.
- the infusion device 150 may display a message that states “move nearer to pump” when the BG meter or controller device senses that the communication with the infusion device 150 is weak or interrupted. A similar message may be displayed if the BG meter or controller device senses some type of problem or malfunction.
- an alarm 162 may alert the user of any problem or malfunction by vibrating, emitting warning sounds, flashing light, and the like.
- the infusion device 150 may provide other functions that show a variety of other displays, for example, when the last bolus was administered, when the last alarm occurred, when the last finger stick was taken, past trends, all alarms that occurred in a time period, calibrations, meals, exercise, bolus schedules, temporary basal delivery, and the like. Whenever a bolus is being delivered, the infusion device 150 can send a message every time a tenth of a unit, or some specified amount, is delivered.
- the controller device 210 includes a housing 215 adapted to be carried by the user.
- a processor 212 contained in the housing 215 is adapted to process data and commands inputted by the user, and a transmitter 218 (or a transceiver 318 (as shown in FIG. 6 b )) contained in the housing 215 and coupled to the processor 212 transmits such communications, including data indicative of the determined concentration of the BG in the user, to the infusion device 250 .
- the controller device 210 may be integrated with a BG meter in one housing, which has a lancing device and receptacle for BG test strips, for obtaining a BG sample from the user.
- the controller device 210 may communicate with a remote station, such as a computer 224 , through a data transfer system, using a type of communication connector 222 , that couples the controller device 210 to the computer 224 and allows the data downloading.
- communication may be by wireless methods, such as RF, IR, Bluetooth or other wireless methods.
- Data may be downloaded via the RF telemetry in the same manner as data is transferred from the controller device 210 to the infusion pump device 250 .
- the transmitter 218 (or a transceiver 318 (as shown in FIG. 6 b )) converts RF signals into compatible electrical pulses that may be subsequently sent through a serial port to a specified destination.
- Data may also be downloaded via RF telemetry, or any other wireless or wired method, from a remote station, such as the computer 224 , to the infusion device 250 .
- remote stations include, but are not limited to, a hospital database, a cellular telephone, a PDA, a smart phone or Internet.
- a cellular phone may be used as a conduit for remote monitoring and programming.
- the controller device may be configured so as to have cellular telephone capabilities.
- the controller device and/or the other devices with display may be capable of providing PDA functions as well, removing the need for patients to carry separate PDA devices.
- the controller device 210 includes on the housing a display 230 that may mimic the display on the infusion pump device 250 .
- the controller device display 230 shows information according to communications sent to the controller device 210 from the infusion device 250 .
- the display of the infusion device 250 may show substantially the same information as shown on the controller device display 230 .
- whatever is shown on the infusion device 250 corresponds to that shown and reflected on the display 230 of the controller device 210 . In this manner, the user may more conveniently view what is being processed or acted upon in the infusion pump device 250 without removing or adjusting the infusion pump device 250 to view the display.
- the controller device 210 may include one or more input device(s) 245 , such as keys, buttons, and the like, on a keypad 265 so that all, or substantially all, viewing and data entry may be performed on the same device without moving the infusion pump device 250 .
- input device(s) 245 such as keys, buttons, and the like
- the infusion pump device 250 and the controller device 210 need to have substantially the same resolution or else the screen may not be presented correctly on the display. Another difficulty may be in properly displaying the scaling of graphs. This issue may be addressed by having the infusion pump device talk in an “ideal” screen, and not necessarily in its actual screen format. As shown in FIG. 7 , the potential communication paths within embodiments of the infusion system are illustrated.
- the controller device 410 may serve as a translator between the infusion device 450 and the other components of the infusion system 400 , such as a BG meter 482 . For example, the controller device 410 may have the ability to determine how best to translate the infusion device's 450 description to the screen of the two displays.
- the infusion device 450 may communicate directly with the BG meter 482 .
- the resolution need not be the same, and the infusion device and/or controller can compensate for the resolution difference so that one or the other may utilize enhanced displays or a simple display depending on the devices and the needs of the user.
- the infusion system 400 may include multiple controllers that can communicate with one infusion device 450 .
- the controller may also be integrated into the infusion device in some embodiments.
- the BG meter 482 may be integrated into the controller 410 , sharing one housing, to both communicate with the infusion pump device 450 .
- the controller is separate from the infusion pump device.
- the infusion device 450 serves as the central hub with most of the intelligence of the system 400 .
- the controller device 410 may be a key fob, in which case, the controller device 410 would serve simply as a virtual keyboard to input data and commands to the infusion device 450 .
- Optional peripheral devices may include a physiological characteristic sensor device, such as a telemetered glucose monitoring system (TGMS) sensor. Alternatively, the sensor may be directly wired to a monitor/user interface.
- the TGMS sensor or physiological characteristic sensor 486 may provide for continuous BG monitoring.
- the physiological characteristic sensor 486 may also be linked to a bedside monitor 492 so that monitoring and programming of medication delivery may be performed remotely.
- the infusion pump device does not include, nor need, a display.
- a key fob may serve as a remote display.
- the infusion device 450 may further communicate with, and download data such as software upgrades and diagnostic tools from, a remote station like a computer 424 from a connector 422 .
- the infusion device 450 may also communicate with the controller device 410 through a station such as a cellular station 488 that includes GPS.
- the connector 422 may have memory capability to transport data.
- the control is maintained in the central hub and the infusion pump device 450 sends out most of the commands.
- the infusion device 450 also sends requests to receive specific data from the controller device 410 .
- the controller device 410 and the infusion pump device 450 may communicate to one another by a connector 422 , other wired methods or by wireless methods, such as RF, IR, Bluetooth, or other wireless methods.
- the infusion pump device 450 may contain all or substantially all of the intelligence.
- the controller device 410 may be limited in the amount of time that they communicate with one another to save power in the controller device 410 . For example, RF communications may be minimized, such that the marriage between the infusion pump device 450 and controller device 410 occurs once.
- the information regarding the screens displayed is sent to the controller device 410 , and when the infusion pump device 450 needs to display a screen, it sends a screen number to the controller device 410 .
- screen displays if the data being sent is fixed, then the screen can be simply displayed. If the data is variable, then the variable data is sent with the screen to the infusion pump device 450 . The screen is then displayed based on a combination of the fixed screen information and the variable data. Exchange IDs, strings to be displayed, and foreign languages are among data that may be sent from the controller device 410 .
- Further commands that may be sent from the infusion pump device 450 include, among other commands, a command to show a specific screen on the controller device 410 , a command for displaying requested information on the screen, a command for showing the rules for the input devices, a command for showing the intelligence about that screen type (e.g., menus, data entries, etc.), and the like.
- the devices may all send diagnostic information to each other, and particularly to the controller device, so that the user may see if anything is going wrong with any of the devices.
- FIG. 8 shows an electronics architecture according to an embodiment of the invention with a custom integrated circuit (“custom IC”) 558 as the processor.
- This architecture can support many of the devices discussed herein, for example the controller device, the infusion device, the characteristic determining device, a BG meter, or any combination of the above.
- the custom IC 558 is in communication with a memory 566 , keypad 565 , audio devices 564 (such as speakers or audio electronic circuitry such as voice recognition, synthesis or other audio reproduction), and a display 560 . Where there is a drive mechanism in a device that includes infusion functions, the custom IC 558 is in communication with a motor 552 or motor drive circuitry or other means of delivering fluids or therapy via an electro-mechanical means.
- the custom IC 558 is in communication with the sensors 580 .
- the electronics architecture further may include a communications block 595 in communication with the custom IC 558 .
- the communications block 595 may be adapted to provide communication via one or more communications methods, such as RF 596 , a USB 597 , and IR 598 .
- the custom IC 558 may be replaced by electronic circuitry, discrete or other circuitry, with similar functions.
- the electronics architecture may include a main battery 590 and a power control 592 .
- the power control 592 may be adapted to give an end of battery warning to the user, which can be predicted based on the type of battery used or can be calculated from the power degradation of the battery being used. However, in certain embodiments it is not necessary to know the type of battery used to create an end of battery warning. Various battery types, such as rechargeable, lithium, alkaline, etc., can be accommodated by this design.
- the electronics architecture includes a removable battery and an internal backup battery. Whenever a new removable battery is inserted, the internal backup battery will be charged to full capacity and then disconnected.
- the internal backup battery may be rechargeable.
- a supercap for example, is used to handle the peak loads that the rechargeable internal battery could not handle directly, because it has sufficient energy storage. This method also allows the use of any type of removable battery (alkaline, lithium, rechargeable, etc.) and partially drained batteries. Depending on use, the backup battery may allow the device to operate for at least one day after the removable battery has been drained or removed.
- a microprocessor measures the charge states and control switches for removable and internal backup batteries.
- the controller device has no user settings and very little memory, because all, or substantially all, needed data and instructions will be sent to the controller device by the infusion pump device.
- the functions are all, or substantially all, contained on the infusion pump device in such embodiments.
- the infusion pump device may include expanded capabilities, such as color on the display screens, and more graph options that can present more detailed graphs. For example, there may be included a graph called “mobile day” where the BG levels of the user for the past five days may be shown as overlapping graphs. The mobile day graph allows the user to see the trend in BG level changes during those days, and aids the user in better controlling the insulin delivery according to the trends that appear for specific times of each day.
- the BG meter may also include expanded capabilities, such as for example, voice synthesis, voice activation, polyphonic speakers for the vision impaired, and plugs on the BG meter for headphones.
- the controller device may also be configured to provide these expanded capabilities.
- the controller device may be integrated with the BG meter in some embodiments.
- the input keys and the display will all, or substantially all, be included on the controller device.
- the BG meter may also be separate from the controller device and may talk directly to a sensing device, such as a TGMS sensor.
- the TGMS sensor is inserted into the subcutaneous tissue of the user to read body fluids, and allows for continuous blood glucose monitoring. The readings are used in conjunction with the BG level determined by the BG meter to continuously monitor BG levels through extrapolating the BG measurements.
- This embodiment would be compatible with users that do not have an infusion pump device, in which case, there is a need for the ability to talk directly to the TGMS sensor without talking to the infusion pump device.
- the TGMS sensor may broadcast the data received from the BG meter to the infusion pump device and the controller device.
- the infusion pump device will always send the data to the controller device.
- the controller device does not receive the information from the infusion pump device, it will assume that the infusion pump device has not received the data and will communicate the value to infusion pump device.
- the infusion pump device, controller device and TGMS sensor maintain a three-way communication with one another, and have the ability to check the contacts between one another.
- the system is set up to automatically call for assistance when analytes reach a certain level.
- the call may include a GPS location.
- the graph displayed on the controller device may display information regarding boluses, finger sticks, exercise, meals and the like.
- the graph displayed has eight segments, representing different limits and an actual BG line.
- the graphs may include additional time spans for which to show the varying BG levels.
- the embodiments may include a 3 hour, 6, 12, and 24 hour graphs. Additional features of the graphs may include the ability to zoom in or out of the graph.
- There may be included an ESC key that will allow the user to return to the last scale. Other options may allow the user to focus on specific positions on a graph.
- the user can select the resolution in which to view the graph.
- the mechanism may have the controller device stop displaying its graph in a “time-out” phase for the time the infusion pump device screen is absent or no more data is entered by the user for a period of time.
- the infusion pump device operates on the last data that the infusion pump device sent to the controller device to display.
- the controller device will display an idle screen during the time-out phase and while the communication between the infusion pump device and the controller device is re-established. The idle screen may remain until the next action is selected by the user.
- the user may press a key to start up the communication again. Once a key is pressed, the controller device will process the key data and the screen will be displayed. The controller device may periodically send signals to the pump to see if it is still active on the screen.
- the graphs may be shown in bitmap packets (e.g., bit-by-bit), and if the user will be getting a large number of packets of data, for example 15 packets of data, to show the graph, the user may opt not to confirm.
- the data is passed from the controller device, which is programmed to display the data, to the infusion pump device.
- the controller device can operate in graphics description language where data is recognized by the controller device as instructing it on which position to put each line or color and the graphics display would handle determining the resolution that the graph would be displayed in.
- the graph may be displayed in three-dimensional format.
- the specific screens to be displayed may include fixed menus, partially variable menus, and variable menus.
- fixed menus the menus do not change depending on data. Therefore, they will always look substantially the same on the screen, and the controller device may be programmed to display them when requested.
- the fixed menus may be described as screen numbers. In this way, the controller device can easily request “screen 1” or “screen 2.”
- fixed menus the text is defined once.
- menus There may also be menus where menu items appear and disappear depending on the current settings of the infusion pump device. These menus are considered partially variable menus because some data appear and disappear, and are not all fixed.
- a program for bolus setup allows a user to change current bolus settings.
- Bolus set up menus involve variable information as well as fixed information.
- Variable menus contain information that is completely variable, e.g., bolus history screen. Variable data is sent at the time of the screen display, and there is generally no fixed text. What is displayed in variable menus depend on what bolus action the user selects.
- the history screens resemble the menu screens in that the user cannot select and input any information with the history screen.
- Data entry screens include multiple fields on a screen and can accept data selection and input by the user.
- Different units may need to be switched dynamically in depending on how the type of entry is communicated.
- the screens may also need to be able to display minimum and maximum values as well as time increments, to ensure precision of the display.
- the rules for this translation will be defined in the infusion pump device.
- Sensor high and low BG values also need to be interlocked (in some embodiments, these two values will be displayed in the same screen).
- communication between the infusion system components takes place when the user presses one or more keys to send data to the infusion pump device and, in response, the infusion pump device can relay to the controller device to instruct on what to display.
- the user may input data through scrolling down menus and selecting options.
- the controller device for example by pressing an “ACT” button, the controller device will then tell the infusion pump what to do, e.g., deliver fluid to the user.
- the controller device is a display only, used to show a BG value and/or graph.
- the controller device embodies only a virtual keypad that may mimic exactly the buttons on the infusion device.
- the controller device tells the infusion device what button was pressed—and the infusion device acts as if the button was pressed on the infusion device itself.
- Each component of the infusion system may be of different degrees of sophistication.
- the controller device can range from a simple key fob with limited capabilities and with, for example, one or two keys to a complex device with memory, many keys and advanced graphing options.
- the controller device may embody all or substantially all of the intelligence that is present in the infusion device.
- the controller device could do all calculations, graphing functions, and other data input, output, and manipulation at the controller device.
- the controller device would then send data to the infusion device indicating what the controller device had done so that the infusion device could be put into the same state as the controller.
- the controller device It is possible for the controller device to have many different degrees of computing intelligence, so that few, none, many, or all computing may be done at the controller device. How much intelligence will be in the controller device may depend on battery life, size requirements, and so forth.
- the processor of the controller device has unique identification information
- the communication transmitted from the controller device to the infusion device further includes the unique identification information of the controller device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
- the processor of the infusion device has unique identification information
- the communication transmitted from the controller device to the infusion device further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
- both the controller device and the BG meter may communicate over wireless networks. Some examples include RF, IR, Bluetooth, spread spectrum communication, and frequency hopping communication. In further embodiments, there may be a “Listen Before Talk” scheme where the system selects the cleanest of allotted channels through which to communicate. Further examples include giving the controller device cellular telephone or pager capabilities.
- the communication may be wired, such as in hospital use. In a wired embodiment, there may be a tether physically connecting the infusion pump device to the controller device and/or BG meter.
- the controller device and the infusion pump device could be both wired and wireless—when wired, the two components communicate by wire, and when disconnected, the two components could operate through wireless communication.
- a transceiver may be used to facilitate data transfer between the PC and the infusion pump device. Such a communication may also be used by a party, other than the user, to control, suspend, and/or clear alarms. This embodiment could be very useful for a parent to monitor the infusion system of a child, or for a physician to monitor the infusion system of a patient.
- the transceiver may allow patients at home or clinicians in a hospital setting to communicate with the various components of the infusion system via RF telemetry.
- the transceiver may be used to download device information from the pump and sent to the PC when the transceiver is connected in to the serial port of the PC.
- the transceiver may derive its power from the PC when the two are connected. In this way, the transceiver conveniently does not require a separate power source.
- a cellular phone may be used as a conduit for remote monitoring and programming.
- the controller device with a BG meter may also act as a transceiver, which would eliminate an extra component.
- the controller device communication system is capable of being deactivated and reactivated.
- the controller device may include input devices, such as keys, buttons, and the like, for inputting commands, and the communication system of the controller device is capable of being deactivated in response to a first command from the user input device and being reactivated in response to a second command from the user input device.
- the communication system of the controller device may be automatically reactivated after a predetermined amount of time has elapsed or at a predetermined time of day.
- the processor of the infusion device uses power cycling such that power is periodically supplied to the communication system of the infusion device until a communication is received from the controller device.
- the processor of the infusion device discontinues using power cycling so that the power is continuously supplied to the infusion device communication system.
- the infusion device processor may then resume using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from a BG meter communication system.
- the infusion system may include a bedside monitor.
- the monitor could communicate through the same avenues as the BG meter, the controller device, and the infusion pump device.
- the monitor could be used, as described above, to remotely alarm people other than the user, such as for example, parents, physicians, nurses, and the like. This would provide an extra layer of monitoring for the user, especially when the user is alone.
- the system may be set up so that multiple devices are placed around the house. This would provide easy access to monitor the diabetic. Additionally, the parent will be able to obtain data to monitor a child user at home and when the parent is away.
- Such home monitors could be set to any mode preferred, for example, flashing lights, warning sounds like beeping, vibration, and the like.
- Other features may include a function that allows the remote user (parent, physician, nurse, etc.) to change and/or deliver a bolus from remote sites.
- the controller device may be configured so as to have cellular telephone capabilities.
- the cellular network could provide a conduit for remote monitoring and programming. Additionally, the cellular network could be used to notify parents, physicians, or emergency services of alarms or alert states.
- a button may be included on the controller device and/or the infusion device to automatically alert a parent, physician, or emergency services when pressed.
- a monitoring device may be built directly into a patient's cellular telephone so that in the case of a hypoglycemic event, an alarm or connection may be made to emergency services via the cellular telephone.
- GPS technology may also be built into the cellular telephone to allow easy location of the patient. Alternatively, GPS technology may be included in the controller device without cellular telephone technology. In other embodiments, the GPS technology may also be built into the infusion pump, BG meter or controller device.
- the infusion system may be part of a closed-loop system, such as an implantable infusion system with a sensor system or an external infusion device with a sensor system.
- a closed-loop system such as an implantable infusion system with a sensor system or an external infusion device with a sensor system.
- safety nets such as alarms and automatic shut-offs.
- the alarms may be customized to specific user needs.
- the alarm may be set to flashing lights for the hearing impaired, or warning sounds and/or vibration for the vision impaired.
- headphones that can plug into the controller device for vision impaired to instruct the user on what to do in the case that an alarm goes off.
- the headphones could also be plugged into a MPEG player or the like.
- the alarms may be handled in a way where the user presses a button on the controller device. Alarms could also be included on the pump.
- There may further be included a turn-off option where, if there is a need to communicate with the controller, the user can choose a selection to turn off the controller.
- any of the devices including an alarm where when the device has sounded an alarm for a period of time and the user has not responded, the alarm will switch to a vibrate mode and/or will attempt to signal companion devices in the system to alarm the user.
- the display and buttons or other input devices may be configured and adapted to the needs of a user with diminished visual and tactile abilities.
- the high level module (and/or the low level module) may communicate to the user by audio signals, such as beeps, speech or the like.
- the high level module may have a memory with which to store customized settings or pump control.
- the memory may be of any type that is known in the art, such as a volatile or non-volatile memory. Both a volatile and non-volatile memory may be used, which can speed up operation of the pump.
- non-volatile memories that could be used in the invention include flash memories, thumb drives and/or memory sticks such as USB thumb drives, removable hard drives, and optical drives.
- the language that the controller device operates in may comprise several different languages, ranging from 1 language to about 40 languages and potentially more.
- data must be first initialized to modify the phrases and detail font that may be significantly different in one language as compared to another language.
- some languages such as Chinese
- One way to overcome this complication in using different languages is to have fonts built into the infusion pump device. Because fonts are now described in pen strokes (true-type fonts), rather than in pixels (bit-by-bit) this allows the infusion pump device to determine out how to display the different fonts.
- Another option could involve uploading the fonts in strings from various sources, such as the internet.
- a food library may be downloaded from a PC, or from the internet via a PC.
- each food item will have some information associated with it, for example, carbohydrate count, fat count, proteins, serving size, and the like.
- the food library may be built directly into the infusion pump device, or it may be downloaded from remote sources, as discussed above.
- the food library may be downloaded through a transceiver embodied by the user's cellular telephone. Other options may include eliminating the need to bypass the transceiver every time a food item is selected, such as, downloading the food items from the PC and storing it until use.
- the food library may also be input directly into the controller device rather than the infusion pump device.
- an associated food library menu could be dynamic. The user could select from different layers of the food library the items consumer or about to be consumed and the infusion pump device could calculate the appropriate amount of insulin to be delivered. Variable data could be included for a small food library with less than 50 food items. For example, there could be variable data for a food library dedicated to breakfast foods only. There could be a “breakfast” key or icon on the controller device that the user can select. There may also be “lunch” and “dinner” and “snack” icons.
- Communications between the system components may be performed in a variety of manners.
- RF options there could be employed a single frequency or a “spread spectrum” where a large range of RFs can be used to relay the communication.
- changing frequencies can be used so as to pick up whatever frequency is present. This is known as “frequency hopping,” where the frequency changes every millisecond or so to take advantage of all, or substantially all, frequencies available. In some cases, frequency hopping allows the system to find frequencies that are not being used by other nearby systems and thus avoid interference.
- a system may operate in a manner where each component-to-component communication is on a different frequency, or where the delay for each communication is different.
- Other types of RF that are not described, may also be used for communication, such as, translation frequency.
- an infusion system includes a controller device, with a controller device display, and an infusion device, with an infusion device display, and a method for infusing a fluid into a body of a user.
- the method includes the steps of: receiving data communication from a user, transmitting with the controller device the communication including data to an infusion device, receiving with the infusion device the communication, and displaying with the controller device display information regarding the fluid delivery, where the display on the controller device display shows information according to instructions or communications sent to the controller device from the infusion device.
- the display of the infusion device may correspond with what is displayed on the infusion device display.
- the method may further include the step of displaying a trends and graphs.
- the method may include the step of inputting an estimate of a material to be ingested by the user, and the estimated amount of fluid to be infused into the body of the user is calculated further based upon the inputted estimate of the material to be ingested by the user.
- a controller device as described herein could be used with any number of therapy/diagnostic devices.
- a controller device may be used that can send commands to the therapy/diagnosis device and/or mimic the display on the therapy/diagnosis device.
- Therapies other than infusion of fluids could include electrical therapy, such as electrical therapy for the brain and for conditions such as epilepsy. Diagnostics could include any number of diagnostics, such as information from cardiac and other sensors.
- Electrical therapy devices include neurostimulation devices for epilepsy, similar devices for pain management, etc.
- electro-acupuncture devices where a needle is inserted into the body much like acupuncture, but additional therapy is delivered by electrical impulses.
- the structure of an electrical therapy device may include a needle that is inserted into appropriate areas of the body.
- the architecture would be similar to that of the devices described above. The patient/user would use the controller device to deliver “dosages” of electrical impulses to alleviate pain and manage neurological symptoms on demand such as twitching, uncontrolled movement of limbs, spasms, and so forth.
- devices such as those used in physical therapy clinics could be adapted for individual use.
- a patch or other device placed on the body could be activated by the controller device to delivery said therapy, be it ultrasound, heat or some other media.
- the architecture for these devices could be similar to the architecture of the devices already described, where a physiological characteristic sensor or infusion device is replaced by a therapy delivering device/mechanism.
- a portable electronic device may receive power from a removable main battery and/or a backup battery.
- an internal backup battery may be charged to full capacity. After the internal backup battery is charged to full capacity, the internal backup battery is disconnected. After the removable main battery has been drained of most of its energy, the main battery may be switched out of the circuit and the internal backup battery is used to supply power to the device. At this time, an indication of a low battery voltage is issued.
- a super capacitor (super cap), charged by the backup battery may have enough energy storage to handle the peak loads that a rechargeable internal battery cannot handle directly.
- This method allows the use of any type of removable battery (alkaline, lithium, or rechargeable) and partially drained batteries.
- the backup battery should allow the device to operate for a known amount of time after the removable main battery has been drained or removed.
- a controller would measure the charge states and operate the control switches for the removable main battery and internal backup battery.
- controller is identified above as performing action for measuring charge states and operating control switches
- a microcontroller, logic, control circuitry, or application specific integrated circuits (ASICs) may be utilized to perform the same actions or other actions below described as being performed by the processor.
- ASICs application specific integrated circuits
- a processor which loads operating software from a location outside of the processor may also perform the actions described above and below that are controlled by the controller. From this point forward, the term controller is utilized but a microcontroller, logic, control circuitry, ASIC(s), or a processor may be utilized to control the same actions.
- the portable electronic device may be a portable personal medical device, such as an insulin pump, a glucose sensor, a transmitter, a pacemaker, or any type of medical monitor.
- the portable electronic device may be a cellular phone, a personal digital assistant, a digital music player, or a Blackberry or Treo type device.
- the present invention applies to any portable electronic device that is powered or can be powered by a removable battery and a backup battery.
- FIG. 9 illustrates a method to provide full functioning power to a portable electronic device after a main battery has reached a low voltage threshold according to an embodiment of the present invention.
- a main battery is inserted 905 into a power circuit for the portable electronic device.
- the main battery may be an alkaline battery, a lithium ion battery, or a rechargeable battery.
- NiCad, NMH, and Lithium batteries are examples of rechargeable batteries.
- a main battery detection circuit in the portable electronic device may detect 910 that the main battery has been inserted into a power circuit and may transmit 910 a power detection signal to a controller or processor of the portable electronic device indicating that a main battery has been detected in the portable electronic device.
- a polarity detection circuit may detect if the battery has been inserted incorrectly.
- the portable electronic device may issue an error message instructing that the battery be placed in the portable electronic device correctly.
- the portable electronic device may compensate for the incorrectly inserted battery. This may occur by a circuit or module in the portable electronic device reversing the coupling of the battery power into a power circuit of the portable electronic device.
- the controller may receive the battery detection signal. After receiving the battery detection signal, the controller may transmit a charge signal or a charging voltage 915 to the backup battery. In other words, the backup battery is being charged through an output of the controller. Accordingly, the backup battery is being charged indirectly by the main battery because the main battery is supplying power to the controller, which in turn supplies power to the backup battery.
- the controller may monitor charging 915 of the backup battery. Once, the backup battery is determined to be charged, the controller may disable charging 920 of the backup battery. In an embodiment of the invention, the controller may determine that a backup battery is charged based on a time measurement or calculation. In other words, the controller may wait a specific period of time (e.g., 24 hours, 48 hours, 12 hours) and then cease to send a charging signal to the battery. In an embodiment of the invention, the controller may monitor a voltage or current of a backup battery. Once the backup battery reaches a charging threshold voltage or current, the controller may cease to supply power to the backup battery.
- the controller may monitor a voltage of the backup battery and after a specific period of time, e.g., 24 hours, 30 hours, or 40 hours, even if the backup battery voltage is not measured to be above the threshold, the controller may stop providing power to the backup battery.
- the charging of the backup battery may take one day or two days. The time required for charging of the backup battery depends on how long the backup battery is utilized for powering the portable electronic device. The charging of the backup battery may, for example, utilize between 2-5% of the main battery's voltage. Under certain operating conditions, the charging of the battery may occur at the time when the main battery is providing power for the portable electronic device.
- the main battery is monitored 925 to determine if the main battery voltage has decreased or has been drained and if a low voltage battery threshold has been met.
- the controller monitors a voltage of the main battery and determines whether or not the main battery voltage has reached a low main battery threshold.
- the low main battery threshold may be 0.8 volts.
- the low battery threshold voltage can be 0.8 volts because it allows a larger percentage of the battery energy to be utilized as compared to prior art systems where the low battery threshold voltage is approximately 1.1 volts. In other words, in previous portable electronic device systems, a message would be transmitted indicating low battery at 1.1 volts (and in some cases disabling the device).
- the low battery threshold voltage may be any value less than 1.0 volt. This is significant because the portable electronic device can run to a lower main battery voltage because a backup battery is present within the system and will provide power to maintain full functionality of the portable electronic device after the main battery has been drained.
- the backup battery may provide the power or voltage for a known minimum time. This results in more energy of the main battery being utilized before the battery has to be replaced or recharged. For example, in prior art systems, about two-thirds of the battery's energy was typically utilized, while with the invention, greater than 95% of the battery's energy may be utilized.
- the low battery threshold can be set to a specific level or to the same level for all of the different types of batteries, e.g., alkaline, rechargeable, or lithium.
- the low battery threshold voltage for the main battery may be 0.8 volts or any other voltage less than 1.0 volt.
- a predetermined amount of time is counted 930 , and then the main battery is monitored again to determine if the main battery voltage has decreased below the low voltage threshold.
- the controller may wait a specified amount of time, e.g., 1 second, 5 seconds, 15 seconds, 1 minute, or 5 minutes, and may again monitor the voltage of the main battery after the specified amount of time has elapsed.
- the controller transmits 935 a disconnect signal to disconnect the main battery from the powering circuit of the portable electronic device.
- the controller may transmit a signal to a switch to close, which results in the main battery being coupled to ground. At this time, the main battery is not providing power for the portable electronic device. Under these operating conditions, the removable main battery can be recharged or replaced.
- the controller transmits 940 a connection signal to connect the backup battery to the powering circuit of the portable electronic device.
- the controller transmits a signal to connect the backup battery.
- the controller or processor may transmit a signal to close a switch to couple the battery into a circuit for powering the portable electronic device.
- the backup battery may be placed into circuit such that the backup battery is in parallel with a capacitor (which may be referred to as a super capacitor or supercap).
- the capacitor or super capacitor may be charged up by the backup battery and may provide power to a boost converter.
- the main battery is also in parallel with the supercap, and the supercap may be charged by the main battery.
- the controller may transmit a message indicating an amount of time for which the backup battery is capable of powering the portable electronic device. This may be a minimum time that the backup battery can provide time for the portable electronic device based on a maximum potential current draw of the portable electronic device.
- the backup battery itself is not utilized to power the electronic circuits and components because the backup battery does not provide smooth enough power for the electronic circuits and components of the portable electronic device. In other words, there may be spikes or ripples within the voltage provided by the backup battery. This may also be true with the main battery because the main battery may not provide smooth or stable power for the electronic circuits and components of the portable electronic device.
- the boost converter provides power for a large number of electronic components (e.g., processors, motors, display modules) in the portable electronic device.
- the backup battery supplies power to the supercap to allow for full functionality of the portable electronic device. In other words, all of the operating features of the portable electronic device can be utilized even when the portable electronic device is being powered by a backup battery.
- the powering of full functionality of the portable electronic device in the present invention is unlike many prior art systems where the backup battery provides power only for a run-time clock and for storing system settings in a CMOS memory.
- the backup battery is able to provide full-functioning power to the portable electronic device for a predetermined time, (e.g., 24 hours when normal battery life for a battery is 30 days). The battery life is dependent on the average energy usage by the portable electronic device.
- the backup battery provides power to allow for full functionality of the portable electronic device for 48 hours (e.g., this is dependent upon the average energy use of the device).
- the controller continues to monitor 950 the main battery to determine if a new or recharged main battery is connected to the charging circuit of the portable electronic device. Once the controller determines a sufficiently charged or new main battery has been installed, the controller transmits 960 a signal to connect the main battery to the charging circuit. The controller also transmits 965 a signal to disconnect the backup battery from providing power to the portable electronic device. The controller also begins to charge 915 the backup battery, as is described above. The controller also starts the monitoring of the main battery voltage.
- FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention.
- the powering subsystem 1000 provides full functional power to the portable electronic device whether the main battery is providing the power or the backup battery is providing the power. This is unlike other powering subsystems for devices utilizing batteries where a backup battery only provides power to support a run-time clock and/or limited functionality for the portable electronic device.
- FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention.
- the powering subsystem 1000 provides full functional power to the portable electronic device whether the main battery is providing the power or the backup battery is providing the power. This is unlike other powering subsystems for devices utilizing batteries where a backup battery only provides power to support a run-time clock and/or limited functionality for the portable electronic device.
- FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention.
- the powering circuit includes a main battery 1010 , a main battery voltage measurement circuit 1020 , a main battery connection circuit 1030 , a main battery detection circuit 1040 , a capacitor 1050 , a voltage converter 1060 , a backup battery 1070 , a controller 1075 , a backup battery connection circuit 1080 , a backup battery monitoring circuit 1090 , and a charging circuit 1095 .
- a main battery detection circuit 1040 monitors whether a main battery 1010 is installed in the portable electronic device. If the main battery is installed within the portable electronic device, the main battery detection circuit 1040 transmits a signal to the controller 1075 identifying that the main battery 1010 is installed.
- a switch 1041 may be opened on a periodic basis, and a voltage may be measured across a resistor 1042 to verify that a voltage is being supplied by the main removable battery 1010 . If a voltage is detected, the main battery detection signal is transmitted to the controller 1075 .
- the controller 1075 transmits a signal request to the main battery voltage measurement circuit 1020 to obtain a voltage reading of the voltage supplied by the main battery 1010 . Under certain other operating conditions, the controller 1075 may wait to receive a voltage level reading from the main battery voltage measurement circuit 1020 .
- the main battery voltage measurement circuit 1020 is measuring the voltage across the super capacitor (supercap) 1050 . In an embodiment of the invention, the main battery voltage measurement circuit 1020 is measuring the voltage supplied by the main battery 1010 .
- the controller 1075 after receipt of the voltage level of the main battery 1010 , compares the received voltage against a low voltage threshold level previously stored in the controller 1075 .
- the low voltage threshold is 0.8 volts.
- the low voltage threshold may be any voltage less than 1.0 volt, such as 0.5, 0.6, 0.72, or 0.93 volts.
- the low voltage threshold may be other voltages also. This is a decrease from previous low voltage thresholds for batteries, which ranged from 1.08 to 1.16 and allows more of the energy of the battery to be utilized for powering the portable electronic device. This results in the portable electric device being able to utilize a larger percentage of the battery energy, e.g., greater than 95% of the battery energy. This allows the user of the portable electronic device to spend less on batteries and also have a predictable time that the backup battery provides power to the portable electronic device.
- the main battery 1010 charges up the capacitor 1050 .
- the capacitor 1050 supplies a voltage to the voltage converter 1060 .
- the main battery 1010 cannot directly provide the power to the components of the portable electronic device, e.g., processors, controllers, or motors, because of the fluctuating characteristics of battery supplied voltage.
- the voltage converter 1060 steps up the voltage to a larger value and provides a plurality of voltages to other systems and components of the portable electronic device. For example, as illustrated in FIG. 10 , the voltage converter 1060 provides a voltage to the controller 1075 .
- the voltage converter 1060 provides voltages to a processor (e.g., like a processor utilized to perform calculations), a display system (for driving a display of the portable electronic device, and a motor (for driving mechanical systems within the portable electronic device).
- a processor e.g., like a processor utilized to perform calculations
- the voltage converter 1060 may receive an input of 0.8 to 2 volts, may step up or boost this voltage and may supply, for example, 3.0 volts, 3.3 volts, and 5.0 volts to the controller 1075 and other systems within the portable electronic device.
- the portable electronic device is an insulin infusion pump.
- the other systems being provided voltage (or power) from the voltage converter 1060 are a display subsystem 1002 for driving a display of the infusion pump, a calculation processor 1004 for calculating a delivery amount of insulin based on input from a user of the infusion pump, and a motor 1006 , for actually driving the delivery of the insulin from the infusion pump to the subject user.
- the controller 1075 receives an operating voltage from the voltage converter 1060 under normal operation.
- the controller 1075 may also transmit a signal to charge the backup battery 1070 .
- the controller 1075 transmits the signal to a charging circuit 1095 which in turn transmits a charging voltage to the backup battery 1070 .
- the controller 1075 may determine the main battery 1010 has enough voltage to operate, but does not have enough voltage to charge the backup battery 1070 .
- the controller 1075 may issue an error message to the user indicating that there is not enough power in the main battery to charge the backup battery and therefore the backup battery is not being charged.
- the controller 1075 determines that the voltage level reading from the main battery 1010 (measured by the main battery voltage measurement circuit 1020 ) is drained below the low battery threshold voltage, the controller 1075 transmits a disconnect signal to the main battery connection circuit 1030 to disconnect the main battery from the powering circuit 1000 .
- the controller 1075 transmits a signal to a main battery connection circuit 1030 to uncouple the main battery 1010 from ground, which disconnects the main battery 1010 from providing power to the capacitor 1050 (and thus the power converter 1060 and microcontroller 1075 ). This does not disconnect power to the portable electronic device because the capacitor 1050 is stored with energy which is utilized and supplied to the converter 1060 . Under certain operating conditions, this is also true when switching from backup battery power to main battery power.
- the controller 1075 transmits a connection signal to the backup battery connection circuit 1080 to make the backup battery 1070 the power supply for the power subsystem 1000 of the portable electronic device.
- the controller 1075 transmits the backup battery connection signal to a switch 1080 that couples the backup battery 1070 to the capacitor 1050 (e.g., super capacitor) to charge the capacitor 1050 .
- the capacitor 1050 After the backup battery charges up the capacitor 1050 , the capacitor 1050 provides a voltage to the converter 1060 which in turn provides operating voltages to the controller or processor 1075 .
- the converter 1060 may also provide power to other devices such as a processor 1002 , display system 1004 , and motor 1006 .
- the backup battery 1070 continues powering the subsystems of the portable electronic device for a minimum established period of time, e.g., 24, 36, or 48 hours, without a user of the portable electronic device worrying that the portable electronic device may fail.
- the backup battery 1070 may provide power for more than the minimum established period of time because the battery life is dependent upon the usage of the portable electronic device.
- the controller 1075 monitors the charge or voltage level of backup battery 1070 by measuring the voltage of the backup battery 1070 .
- a backup battery voltage detection circuit 1090 measures the voltage level of the backup battery 1070 and transmits a voltage level signal to the controller 1075 .
- the controller 1075 receives the backup battery voltage level and compares it to a backup battery low threshold voltage. If the backup battery voltage level is below the backup battery low threshold voltage, the controller 1075 may transmit a message to a user that it is shutting down the portable electronic device or risk operational failure of the portable electronic device. This occurs only if a new main battery 1010 has not been inserted after the portable electronic device switched to being powered by the backup battery.
- the main battery detection circuit 1040 determines that the new or recharged main battery 1010 has been placed into the powering subsystem 1000 . If the main battery detection circuit 1040 detects the new main or recharged main battery 1010 , a battery detection signal is transmitted to the controller 1075 . The controller 1075 receives the battery detection signal and transmits the connection signal to the main battery connection circuit 1030 to place the main battery 1010 in parallel with the super capacitor 1050 to provide functional power to the portable electronic device (through the power converter 1060 ). The controller 1075 also transmits a backup battery connection signal to disconnect the backup battery 1070 from charging up the super capacitor 1050 .
- the backup battery 1070 is no longer providing the power for the portable electronic device.
- the controller 1075 also charges up the backup battery 1070 , either directly or through the backup battery charging circuit 1095 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Power Engineering (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Business, Economics & Management (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Emergency Management (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Charge And Discharge Circuits For Batteries Or The Like (AREA)
- Secondary Cells (AREA)
Abstract
A powering subassembly for a portable electronic device includes a main battery, a converter, a backup battery, and a controller. The main battery provides a main voltage and the backup battery can provide a backup voltage. The converter receives the main voltage and increases it to at least one operating voltage. The controller receives the operating voltage from the converter, monitors the voltage of the main battery, and compares the monitored voltage to a main battery low voltage threshold. The controller transmits a disconnect signal to decouple the main battery from the converter if the monitored voltage from the main battery is less than the main battery low voltage threshold. The controller transmits a connection signal to couple the backup battery to the converter if the monitored voltage is less than the main battery low voltage threshold. The backup battery provides the power for a predetermined minimum amount of time.
Description
- This is a continuation of U.S. patent application Ser. No. 12/768,424, filed Apr. 27, 2010, now U.S. Pat. No. ______, which is a continuation of U.S. patent application Ser. No. 11/447,637, filed Jun. 6, 2006, now U.S. Pat. No. 7,737,581, which is a continuation-in-part of U.S. patent application Ser. No. 11/204,667, filed Aug. 16, 2005, and U.S. patent application Ser. No. 11/204,583, filed Aug. 16, 2005, all of which are incorporated by reference herein.
- 1. Field of the Invention
- The field of the invention is the providing of power for portable electronic devices, such as insulin pumps, analyte sensor devices, portable phones, personal digital assistants, etc. Specifically, the invention is directed to powering a portable electronic device for a known period of time after depletion of the main battery regardless of the type of battery that is installed in the portable electronic device.
- 2. Description of Related Art
- Most portable electronic devices are powered by either an alkaline battery, a lithium-ion battery, or a rechargeable battery.
FIG. 1( a) illustrates a voltage level over time provided by different types of batteries. As illustrated by Line A inFIG. 1( a), the alkaline battery starts out at a high voltage, e.g., approximately 1.55 volts, and decreases over time. Line D represents a battery threshold voltage. This low battery threshold voltage represents a value at which the battery is determined to be providing a low voltage. Once this threshold is reached, a message will need to be transmitted to a display of the portable electronic device indicating that the battery is running low, and should be replaced. If the portable electronic device is utilizing an alkaline battery, the voltage threshold may be around 1.16 or 1.08 volts. After the low battery threshold is reached in an alkaline battery, the alkaline battery can normally provide power to the portable electronic device for approximately twelve hours, assuming that the main battery life of the alkaline battery is 30 days. It should be noted that battery life is dependent on actual energy used by the device. Also, it also should be noted that due to the voltage threshold being around 1.1 volts, it is estimated that only two-thirds of the battery energy of the alkaline battery is utilized. - A lithium battery is capable of providing a much higher initial voltage and sustaining the value of that voltage for a long period of time. However, as illustrated by line B in FIG. 1(a), once the lithium battery becomes drained, the decrease in voltage value is rapid. If a lithium battery is being used in a portable electronic device, a user of the portable electronic device may have less than 30 minutes after receiving a low voltage message before the portable electronic device loses power. If the user is utilizing the portable electronic device for medical reasons, e.g., like an insulin pump, blood glucose sensor or meter, this may not provide the user with enough time to find a replacement battery.
- A rechargeable battery can be a good economic solution for an owner of a portable electronic device. Rather than buying a new set of batteries every week or every month, the user may utilize household current to charge up the battery after the battery has expended its energy. Many portable electronic devices cannot utilize rechargeable batteries because the initial voltage supplied by the battery is too low and sometimes is not greater than the low battery threshold voltage set for alkaline batteries. The rechargeable battery has characteristics similar to the alkaline battery in terms of how long it can power a device, but as illustrated by Line C in
FIG. 1( a), the initial voltage supplied by the rechargeable battery is lower than the initial voltage supplied by the alkaline battery. Accordingly, some initial voltages for rechargeable batteries may be lower than the low battery threshold voltage for the portable electronic device, as is mentioned above, and the portable electronic device may generate a message indicating that the rechargeable battery cannot be utilized. This is also true in regards to partially drained batteries, which may have low initial voltage readings. - In addition, the effective voltage of any of these batteries can be affected by the environment in which the battery is stored or utilized. For example, a temperature change in the environment in which the battery is located, can reduce the effective voltage provided by the battery. Also, subjecting the battery to vibration can result in a lowering of the effective voltage generated by the battery. This results in the battery providing a voltage reading that is lower than the low battery threshold and thus the portable electronic device may be unable to utilize the batteries subjected to changes in temperature as well as vibration.
- Many current portable electronic devices that utilize a DC power source also include a backup battery system that provides a limited amount of functionality for the portable electronic device until the DC power source is replaced or recharged. In other words, the backup battery may provide enough energy to operate a run time clock for the portable electronic device and to save the contents of a memory, but does not provide power for full functionality of the portable electronic device.
- In accordance with embodiments of the invention, a method of providing backup power to a portable electronic device is provided. In embodiments of the invention a battery level of a primary battery is monitored. A disconnect signal is generated to cause the primary battery to be disconnected if the battery level of the primary battery is below a low battery threshold. A connection signal is generated to couple a backup battery to power the portable electronic device if the battery level of the primary battery is below the low battery threshold. The backup battery provides power for operating the portable electronic device for a predetermined minimum time regardless of what type of battery is utilized in the portable electronic device.
- In further embodiments, the portable electronic device detects whether the main battery has been inserted into the portable electronic device and a detection signal is transmitted to a controller if the main battery is detected. If the main battery has been detected, a voltage output from the main battery is coupled to a power converter. The converter provides an operating voltage to the controller after receiving the voltage from the main battery. The controller charges a backup battery utilizing a signal transmitted from the controller. The controller monitors the battery level of the backup battery to determine if the backup battery has been fully charged. The controller disables charging of the backup battery if the charging level of the backup battery has been exceeded, which represents that the backup battery is adequately charged.
-
FIG. 1( a) illustrates a voltage level over time provided by different types of batteries; -
FIG. 1( b) illustrates a front view of a controller device according to an embodiment of the invention; -
FIG. 2 illustrates a front view of a blood glucose meter integrated into the controller device housing according to an embodiment of the present invention; -
FIG. 3 is a front view of a blood glucose meter integrated into a controller device housing according to an embodiment of the present invention; -
FIG. 4 is a front view of a blood glucose meter integrated into a controller device housing communicating with an infusion device according to an embodiment of the present invention; -
FIG. 5 provides a block diagram of a RF communication system in the infusion device according to an embodiment of the present invention; -
FIG. 6 a is a block diagram of a the controller device according to an embodiment of the present invention; -
FIG. 6 b is a block diagram of a controller device according to an embodiment of the invention; -
FIG. 7 is a block diagram of communication paths within the infusion system according to an embodiment of the present invention; -
FIG. 8 is a diagram of an electronics architecture according to an embodiment of the invention with a custom integrated circuit; -
FIG. 9 illustrates a method to provide full functioning power to a portable electronic device after a main battery has reached a low voltage threshold according to an embodiment of the present invention; and -
FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention. - In the following description, reference is made to the accompanying drawings which form a part hereof and which illustrate several embodiments of the present inventions. It is understood that other embodiments may be utilized and structural and operational changes may be made without departing from the scope of the present inventions.
- In one embodiment, the controller device is a hand-held device separate from the therapy/diagnostic device, such as an infusion device, that allows the user to communicate with the therapy/diagnostic device without actually handling the device. Other examples of therapy/diagnostic devices include electronic therapy devices and devices that receive diagnostic information from cardiac and other sensors. As illustrated in
FIG. 1( b), thecontroller device 5 includes ahousing 3 adapted to be carried by the user and a communication system (not shown) contained in thehousing 3 for transmitting a communication or command from the user to the infusion device. In further embodiments, thecontroller device 5 may receive communications sent from the infusion device or other components of the infusion system, such as for example, a characteristic determining device. Further, the controller device may include one or moreuser input devices controller device housing 3, such as keys, buttons, or the like, for the user to input data or commands. Thecontroller device 5 includes a display 4 on thecontroller device housing 3 which simultaneously displays whatever information and/or graph is being displayed on the infusion device display at that moment. The display 4 allows a user to easily monitor and control what actions are taking place in, or being performed by, the infusion device. In some embodiments, thecontroller device 5 may further include abacklight 1 in the controller device display 4 for easier viewing. The backlight may be adapted to be in one or more colors, which can be user selectable for personalized use. In further embodiments, the backlight may be adapted to flash and/or turn to a color such as yellow or red when various alerts and alarms take place. In additional embodiments, thecontroller device 5 may include accessories such ashand straps 6 to provide convenient handling. In particular embodiments, the controller is sized smaller than 6 inches long by 4 inches wide by 1 inch thick. - In certain embodiments, a characteristic determining device that senses and determines the concentration of an analyte of a patient, for example blood glucose (“BG”), and controls the infusion device according to the measurements, may be included in an infusion system with the controller device and the infusion device. The characteristic determining device includes a housing, a receptacle coupled to the housing for receiving and testing an analyte from the user to determine a concentration of the analyte in the user, a processor contained in the housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle, and a communication system contained in the housing and coupled to the processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user. In particular embodiments, the characteristic determining device may also include a lancing device coupled to the receptacle for obtaining the analyte from the user.
- In embodiments, the infusion device includes a housing adapted to be carried by the user, a drive mechanism contained in the housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user, a communication system contained in the housing for receiving the communication including the data indicative of the determined concentration of an analyte in the user from a characteristic determining device, and a processor contained in the housing and coupled to the communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device. In particular embodiments, the infusion device is sized smaller than 6 inches long by 4 inches wide by 1 inch thick.
- The infusion device may further include a bolus estimator used in conjunction with the processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated. The system may determine the concentration of one of any variety of analyte types including, but not limited to, oxygen, blood, temperature, lactase, pH, implantable, and the like. Additionally, the infusion device may include a user input device, such as keys, buttons, or the like, for inputting an estimate of a material to be ingested by the user, and the bolus estimator may include the capability to calculate the estimated amount of fluid to be infused into the body of the user based upon the inputted estimate of the material to be ingested by the user. The infusion device may also include a memory for storing the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system.
- In still further alternative embodiments, the characteristic determining device is a BG measurement device and may use samples from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like. In yet other alternative embodiments, other measurement devices may be utilized to determine the concentrations, levels, or quantities of other characteristics, analytes, or agents in the user, such as hormones, cholesterol, oxygen, pH, lactate, heart rate, respiratory rate, medication concentrations, viral loads (e.g., HIV), or the like. In still other alternative embodiments, other fluids may be delivered to the user, such as medication other than insulin (e.g., HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, and anti-cancer treatments), chemicals, enzymes, antigens, hormones, vitamins, or the like. Particular embodiments are directed towards the use in humans; however, in alternative embodiments, the infusion devices may be used in animals. For pain management, a bolus function may be set up as a Patient Controlled Analgesic (PCA) function for customized delivery or the user may press a preset bolus button several times.
- In other embodiments, the characteristic determining device is a BG meter that determines BG level and the infusion device is an insulin infusion pump. The BG meter communicates the measurement of BG to the infusion pump device to determine the amount of insulin for delivery to the user. In alternative embodiments, the BG measurement device may be a continuous glucose measurement system, a hospital hemacue, an automated intermittent blood glucose measurement system, and the like, and/or the BG measurement device may use other methods for measuring the user's BG level, such as a sensor in contact with a body fluid, an optical sensor, a RF sensor, an enzymatic sensor, a fluorescent sensor, a blood sample placed in a receptacle, or the like. The BG measurement device may generally be of the type and/or include features disclosed in U.S. patent applications Ser. No. 09/377,472 filed Aug. 19, 1999 and entitled “Telemetered Characteristic Monitor System and Method of Using the Same,” Ser. No. 09/334,996 filed Jun. 17, 1999 and entitled “Characteristic Monitor with a Characteristic Meter and Method of Using the Same,” Ser. No. 09/487,423 filed Jan. 20, 2000 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” and Ser. No. 09/935,827 filed Aug. 23, 2001 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” which are herein incorporated by reference. Such BG measurement devices may be adapted to be carried by the user, for example, in the hand, on the body, in a clothing pocket, attached to clothing (e.g., using a clip, strap, adhesive, or fastener), and the like. In particular embodiments, the BG measurement device is sized smaller than 6 inches long by 4 inches wide by 1 inch thick.
- In alternative embodiments of the invention, the BG meter may be integrated into the controller device housing, as shown in
FIG. 2 , where thecontroller device housing 15 includes aBG meter receptacle 20. Thecontroller 10 includes ahousing 15 adapted to be carried by the user, aBG meter receptacle 20 coupled to thehousing 15 for receiving and testing BG level from the user to determine a concentration of the BG in the user. ABG test strip 25 that holds a use blood sample is inserted into theBG meter receptacle 20 for the testing by thecontroller device 10. In variations, thecontroller device 10 may have a cartridge-like mechanism which loads and presents the strip for testing and then ejects it. Thecontroller device 10 has adisplay 30 on thehousing 15 to show information requested by the user or an instructed act that was undertaken by the infusion device, such as for example, determined concentration of blood glucose levels, BG trends or graphs, such as described and disclosed in U.S. patent application Ser. No. 10/624,177, entitled “System for Monitoring Physiological Characteristics,” which is herein incorporated by reference. Thedisplay 30 may further include adedicated backlight 35 to facilitate viewing. Thebacklight 35 may be a user programmable multi-color backlight that additionally performs the function of a visual indicator by flashing colors appropriate to the level of an alert or alarm. Thebacklight 35 may also have variable intensity (automatic or manual) to preserve the battery power and improved viewing. Thecontroller 10 includes akeypad 40 on which various input devices, such as keys, buttons, or the like, are located. Thekeypad buttons - The power of the controller device and of the other various devices discussed herein may be provided from a battery. The battery may be a single use or a rechargeable battery. Where the battery is rechargeable, there may be a connector or other interface on a device to attach the device to an electrical outlet, docking station, portable recharger, or so forth to recharge the battery while in the device. It is also possible that a rechargeable battery may be removable from the device for recharging outside of the device, however, in some cases, the rechargeable battery may be sealed into the housing of the device to create a more water resistant or waterproof housing. The devices may be adapted to accommodate various battery types and shapes. In further embodiments, the devices may be adapted to accommodate more than one type of battery. For example, a device may be adapted to accommodate a rechargeable battery and, in the event of battery failure or other need, also adapted to accommodate a readily available battery, such as a AA battery, AAA battery, or coin cell battery.
- In
FIG. 3 , another embodiment of a controller device is shown. Again, thecontroller device 110 includes ahousing 115 adapted to be carried by the user, and aBG meter receptacle 120 coupled to thehousing 115 for receiving and testing BG level from the user to determine a concentration of the BG in the user. ABG test strip 125 that holds a user's blood sample is inserted into theBG meter receptacle 120 for the testing by thecontroller device 110. Thecontroller device 110 has adisplay 130 on thehousing 115 to show information requested by the user or an instructed act that was undertaken by the infusion device, such as for example, determined concentration of blood glucose levels, graphs of blood glucose level trends or fluid delivery information. Thedisplay 130 may include adedicated backlight 135 to facilitate viewing. Thecontroller device 110 includes a few input devices, such as keys, buttons, or the like, on thehousing 115. Thehousing buttons -
FIG. 4 illustrates an embodiment of an infusion system that includes aninfusion device 50, and further includes a controller device integrated with aBG meter 10, where both share one housing. Thecontroller device 10 communicates to theinfusion pump device 50 through a wireless method, for example RF signals. Thecontroller device 10 senses and determines the concentration of BG level of a patient and controls theinfusion device 50 according to the measurements. This substantially reduces, if not eliminates, calculations on the part of the patient. In particular embodiments, theinfusion device 50 includes ahousing 55 adapted to be carried by the user. On thehousing 55 there is included adisplay 60 that, like theBG meter display 30, shows information requested by the user or an instructed act that was undertaken by theinfusion device 50. Theinfusion device 50 may not include a display, but in that case there should be a suspend/resume input and an action input for safety reasons. TheBG meter display 30 shows information according to communications sent to thecontroller device 10 from theinfusion device 50. At any moment, thedisplay 60 of theinfusion device 50 may show substantially the same information as shown on thecontroller device display 30. The two displays may mimic one another so that the user may choose to conveniently view the selected information from thecontroller device 10 rather than theinfusion device 50, which is usually attached to the user's body through the infusion set 75. Theinfusion device 50 delivers fluid from within thehousing 55, throughtubing 80 and into the infusion set 75 into the user's body at an infusion site. Further included on theinfusion device 50 is akeypad 65 with various input devices, such as thekeypad buttons -
FIG. 5 provides a block diagram of theinfusion device 150. Theinfusion device 150 includes adrive mechanism 152 contained in thehousing 172 and operatively coupled with areservoir 154 containing the fluid for infusing the fluid into the body of the user, acommunication system 156 contained in thehousing 172 for receiving the communication from the controller device including data indicative of the determined concentration of the BG in the user from the BG meter, and aprocessor 158 contained in thehousing 172 and coupled to thecommunication system 156 for processing the received communications and controlling theinfusion device 150. The fluid is delivered from thereservoir 154 through anoutlet 168 in thehousing 172 and into the user's body via thetubing 180 and infusion set 175. Theinfusion device 150 may further include an indicator displayed on thedisplay 160 to indicate when the estimated amount of fluid to be infused has been calculated. Additionally, theinfusion device 150 may include one or more user input device(s), such as keys, buttons, and the like, for inputting an estimate of a material to be ingested by the user, and the estimated amount of fluid to be infused into the body of the user may be based upon this inputted estimate of material to be ingested. A bolus estimator may be used in conjunction with the infusion device processor for estimating the appropriate amount of fluid to be infused into the body of the user. There may be included akeypad 165 on which the one or more input device(s) are located. Theinfusion device 150 may also include a memory 166 for storing the data received by the infusiondevice communication system 156 from the controller device communication system. - In further embodiments, a
speaker 164 is included to provide an alternative mode of communication. In an embodiment, theinfusion device 150 may display a message that states “move nearer to pump” when the BG meter or controller device senses that the communication with theinfusion device 150 is weak or interrupted. A similar message may be displayed if the BG meter or controller device senses some type of problem or malfunction. Alternatively, analarm 162 may alert the user of any problem or malfunction by vibrating, emitting warning sounds, flashing light, and the like. In further embodiments, theinfusion device 150 may provide other functions that show a variety of other displays, for example, when the last bolus was administered, when the last alarm occurred, when the last finger stick was taken, past trends, all alarms that occurred in a time period, calibrations, meals, exercise, bolus schedules, temporary basal delivery, and the like. Whenever a bolus is being delivered, theinfusion device 150 can send a message every time a tenth of a unit, or some specified amount, is delivered. - As seen in
FIG. 6 a, thecontroller device 210, includes ahousing 215 adapted to be carried by the user. Aprocessor 212 contained in thehousing 215 is adapted to process data and commands inputted by the user, and a transmitter 218 (or a transceiver 318 (as shown inFIG. 6 b)) contained in thehousing 215 and coupled to theprocessor 212 transmits such communications, including data indicative of the determined concentration of the BG in the user, to theinfusion device 250. In further embodiments, thecontroller device 210 may be integrated with a BG meter in one housing, which has a lancing device and receptacle for BG test strips, for obtaining a BG sample from the user. - The
controller device 210 may communicate with a remote station, such as acomputer 224, through a data transfer system, using a type ofcommunication connector 222, that couples thecontroller device 210 to thecomputer 224 and allows the data downloading. Alternatively, communication may be by wireless methods, such as RF, IR, Bluetooth or other wireless methods. Data may be downloaded via the RF telemetry in the same manner as data is transferred from thecontroller device 210 to theinfusion pump device 250. The transmitter 218 (or a transceiver 318 (as shown inFIG. 6 b)) converts RF signals into compatible electrical pulses that may be subsequently sent through a serial port to a specified destination. Data, including software upgrades and diagnostic tools, may also be downloaded via RF telemetry, or any other wireless or wired method, from a remote station, such as thecomputer 224, to theinfusion device 250. Other remote stations include, but are not limited to, a hospital database, a cellular telephone, a PDA, a smart phone or Internet. For example, a cellular phone may be used as a conduit for remote monitoring and programming. In one embodiment, the controller device may be configured so as to have cellular telephone capabilities. In further embodiments, the controller device and/or the other devices with display may be capable of providing PDA functions as well, removing the need for patients to carry separate PDA devices. - The
controller device 210 includes on the housing adisplay 230 that may mimic the display on theinfusion pump device 250. Thecontroller device display 230 shows information according to communications sent to thecontroller device 210 from theinfusion device 250. At any moment, the display of theinfusion device 250 may show substantially the same information as shown on thecontroller device display 230. In some embodiments, whatever is shown on theinfusion device 250 corresponds to that shown and reflected on thedisplay 230 of thecontroller device 210. In this manner, the user may more conveniently view what is being processed or acted upon in theinfusion pump device 250 without removing or adjusting theinfusion pump device 250 to view the display. In embodiments, thecontroller device 210 may include one or more input device(s) 245, such as keys, buttons, and the like, on akeypad 265 so that all, or substantially all, viewing and data entry may be performed on the same device without moving theinfusion pump device 250. - The
infusion pump device 250 and thecontroller device 210 need to have substantially the same resolution or else the screen may not be presented correctly on the display. Another difficulty may be in properly displaying the scaling of graphs. This issue may be addressed by having the infusion pump device talk in an “ideal” screen, and not necessarily in its actual screen format. As shown inFIG. 7 , the potential communication paths within embodiments of the infusion system are illustrated. Thecontroller device 410 may serve as a translator between theinfusion device 450 and the other components of theinfusion system 400, such as aBG meter 482. For example, thecontroller device 410 may have the ability to determine how best to translate the infusion device's 450 description to the screen of the two displays. As can be seen, theinfusion device 450 may communicate directly with theBG meter 482. In alternative embodiments, the resolution need not be the same, and the infusion device and/or controller can compensate for the resolution difference so that one or the other may utilize enhanced displays or a simple display depending on the devices and the needs of the user. - In some embodiments, the
infusion system 400 may include multiple controllers that can communicate with oneinfusion device 450. In other embodiments, there is onecontroller 410 communicating to oneinfusion device 450. The controller may also be integrated into the infusion device in some embodiments. In yet another embodiment, theBG meter 482 may be integrated into thecontroller 410, sharing one housing, to both communicate with theinfusion pump device 450. In this embodiment, the controller is separate from the infusion pump device. In this embodiment, theinfusion device 450 serves as the central hub with most of the intelligence of thesystem 400. In yet another embodiment, thecontroller device 410 may be a key fob, in which case, thecontroller device 410 would serve simply as a virtual keyboard to input data and commands to theinfusion device 450. Optional peripheral devices may include a physiological characteristic sensor device, such as a telemetered glucose monitoring system (TGMS) sensor. Alternatively, the sensor may be directly wired to a monitor/user interface. The TGMS sensor or physiologicalcharacteristic sensor 486 may provide for continuous BG monitoring. The physiologicalcharacteristic sensor 486 may also be linked to abedside monitor 492 so that monitoring and programming of medication delivery may be performed remotely. In some embodiments, the infusion pump device does not include, nor need, a display. In this embodiment, a key fob may serve as a remote display. Other options for a remote display include, but are not limited to, cellular telephones, computer monitors, PDA's, smart phones, watch remotes, and the like. Theinfusion device 450 may further communicate with, and download data such as software upgrades and diagnostic tools from, a remote station like acomputer 424 from aconnector 422. Optionally, theinfusion device 450 may also communicate with thecontroller device 410 through a station such as acellular station 488 that includes GPS. In further embodiments, theconnector 422 may have memory capability to transport data. - In the above embodiment, the control is maintained in the central hub and the
infusion pump device 450 sends out most of the commands. Theinfusion device 450 also sends requests to receive specific data from thecontroller device 410. Thecontroller device 410 and theinfusion pump device 450 may communicate to one another by aconnector 422, other wired methods or by wireless methods, such as RF, IR, Bluetooth, or other wireless methods. In other embodiments, theinfusion pump device 450 may contain all or substantially all of the intelligence. Thecontroller device 410 may be limited in the amount of time that they communicate with one another to save power in thecontroller device 410. For example, RF communications may be minimized, such that the marriage between theinfusion pump device 450 andcontroller device 410 occurs once. The information regarding the screens displayed is sent to thecontroller device 410, and when theinfusion pump device 450 needs to display a screen, it sends a screen number to thecontroller device 410. In the case of screen displays, if the data being sent is fixed, then the screen can be simply displayed. If the data is variable, then the variable data is sent with the screen to theinfusion pump device 450. The screen is then displayed based on a combination of the fixed screen information and the variable data. Exchange IDs, strings to be displayed, and foreign languages are among data that may be sent from thecontroller device 410. Further commands that may be sent from theinfusion pump device 450 include, among other commands, a command to show a specific screen on thecontroller device 410, a command for displaying requested information on the screen, a command for showing the rules for the input devices, a command for showing the intelligence about that screen type (e.g., menus, data entries, etc.), and the like. The devices may all send diagnostic information to each other, and particularly to the controller device, so that the user may see if anything is going wrong with any of the devices. -
FIG. 8 shows an electronics architecture according to an embodiment of the invention with a custom integrated circuit (“custom IC”) 558 as the processor. This architecture can support many of the devices discussed herein, for example the controller device, the infusion device, the characteristic determining device, a BG meter, or any combination of the above. Thecustom IC 558 is in communication with amemory 566,keypad 565, audio devices 564 (such as speakers or audio electronic circuitry such as voice recognition, synthesis or other audio reproduction), and adisplay 560. Where there is a drive mechanism in a device that includes infusion functions, thecustom IC 558 is in communication with amotor 552 or motor drive circuitry or other means of delivering fluids or therapy via an electro-mechanical means. Where there are one more sensors included in the device, or in communication with the device (such as a characteristic determining device or a device which includes a characteristic determining function), thecustom IC 558 is in communication with thesensors 580. The electronics architecture further may include acommunications block 595 in communication with thecustom IC 558. The communications block 595 may be adapted to provide communication via one or more communications methods, such asRF 596, aUSB 597, andIR 598. In further embodiments, thecustom IC 558 may be replaced by electronic circuitry, discrete or other circuitry, with similar functions. - The electronics architecture may include a
main battery 590 and apower control 592. Thepower control 592 may be adapted to give an end of battery warning to the user, which can be predicted based on the type of battery used or can be calculated from the power degradation of the battery being used. However, in certain embodiments it is not necessary to know the type of battery used to create an end of battery warning. Various battery types, such as rechargeable, lithium, alkaline, etc., can be accommodated by this design. In certain embodiments, the electronics architecture includes a removable battery and an internal backup battery. Whenever a new removable battery is inserted, the internal backup battery will be charged to full capacity and then disconnected. After the removable battery has been drained of most of its energy, it will be switched out of the circuit and the internal backup battery will be used to supply power to the device. A low battery warning may then be issued. The internal backup battery may be rechargeable. In further embodiments, a supercap, for example, is used to handle the peak loads that the rechargeable internal battery could not handle directly, because it has sufficient energy storage. This method also allows the use of any type of removable battery (alkaline, lithium, rechargeable, etc.) and partially drained batteries. Depending on use, the backup battery may allow the device to operate for at least one day after the removable battery has been drained or removed. In further embodiments, a microprocessor measures the charge states and control switches for removable and internal backup batteries. These embodiments of the invention are discussed in detail below. - In certain embodiments, the controller device has no user settings and very little memory, because all, or substantially all, needed data and instructions will be sent to the controller device by the infusion pump device. Thus, the functions are all, or substantially all, contained on the infusion pump device in such embodiments.
- In alternative embodiments, the infusion pump device may include expanded capabilities, such as color on the display screens, and more graph options that can present more detailed graphs. For example, there may be included a graph called “mobile day” where the BG levels of the user for the past five days may be shown as overlapping graphs. The mobile day graph allows the user to see the trend in BG level changes during those days, and aids the user in better controlling the insulin delivery according to the trends that appear for specific times of each day.
- The BG meter may also include expanded capabilities, such as for example, voice synthesis, voice activation, polyphonic speakers for the vision impaired, and plugs on the BG meter for headphones. Likewise, the controller device may also be configured to provide these expanded capabilities.
- As described above, the controller device may be integrated with the BG meter in some embodiments. In those embodiments, the input keys and the display will all, or substantially all, be included on the controller device. The BG meter may also be separate from the controller device and may talk directly to a sensing device, such as a TGMS sensor. The TGMS sensor is inserted into the subcutaneous tissue of the user to read body fluids, and allows for continuous blood glucose monitoring. The readings are used in conjunction with the BG level determined by the BG meter to continuously monitor BG levels through extrapolating the BG measurements. This embodiment would be compatible with users that do not have an infusion pump device, in which case, there is a need for the ability to talk directly to the TGMS sensor without talking to the infusion pump device.
- If the BG meter talks to the TGMS sensor then the TGMS sensor may broadcast the data received from the BG meter to the infusion pump device and the controller device. In some embodiments, the infusion pump device will always send the data to the controller device. In the case that the controller device does not receive the information from the infusion pump device, it will assume that the infusion pump device has not received the data and will communicate the value to infusion pump device. In other embodiments, the infusion pump device, controller device and TGMS sensor maintain a three-way communication with one another, and have the ability to check the contacts between one another. In still further embodiments, the system is set up to automatically call for assistance when analytes reach a certain level. The call may include a GPS location.
- In an embodiment of the present invention, the graph displayed on the controller device may display information regarding boluses, finger sticks, exercise, meals and the like. In one embodiment, the graph displayed has eight segments, representing different limits and an actual BG line. In other embodiments, the graphs may include additional time spans for which to show the varying BG levels. For example, the embodiments may include a 3 hour, 6, 12, and 24 hour graphs. Additional features of the graphs may include the ability to zoom in or out of the graph. There may be included an ESC key that will allow the user to return to the last scale. Other options may allow the user to focus on specific positions on a graph. In yet another feature, the user can select the resolution in which to view the graph.
- In a situation where the infusion pump device and the controller device are out of sync, e.g., the graph on the pump and the graph on the controller device do not look substantially the same, there needs to be a way to resynchronize the two components if something goes wrong. For example, if finger stick values do not both have current finger stick values, then the graphs for the controller device and the infusion pump device would be different.
- There also may be some type of positive mechanism for the controller device if the communication between the controller device and the pump are interrupted. For example, the mechanism may have the controller device stop displaying its graph in a “time-out” phase for the time the infusion pump device screen is absent or no more data is entered by the user for a period of time. In this case, the infusion pump device operates on the last data that the infusion pump device sent to the controller device to display. In an embodiment, the controller device will display an idle screen during the time-out phase and while the communication between the infusion pump device and the controller device is re-established. The idle screen may remain until the next action is selected by the user. After the time-out phase, the user may press a key to start up the communication again. Once a key is pressed, the controller device will process the key data and the screen will be displayed. The controller device may periodically send signals to the pump to see if it is still active on the screen.
- In alternative embodiments, there will be a positive confirmation requested prior to displaying graphs. For example, the graphs may be shown in bitmap packets (e.g., bit-by-bit), and if the user will be getting a large number of packets of data, for example 15 packets of data, to show the graph, the user may opt not to confirm. The data is passed from the controller device, which is programmed to display the data, to the infusion pump device. The controller device can operate in graphics description language where data is recognized by the controller device as instructing it on which position to put each line or color and the graphics display would handle determining the resolution that the graph would be displayed in. In some embodiments, the graph may be displayed in three-dimensional format.
- The specific screens to be displayed may include fixed menus, partially variable menus, and variable menus. In fixed menus, the menus do not change depending on data. Therefore, they will always look substantially the same on the screen, and the controller device may be programmed to display them when requested. The fixed menus may be described as screen numbers. In this way, the controller device can easily request “
screen 1” or “screen 2.” In fixed menus, the text is defined once. There may also be menus where menu items appear and disappear depending on the current settings of the infusion pump device. These menus are considered partially variable menus because some data appear and disappear, and are not all fixed. For example, a program for bolus setup allows a user to change current bolus settings. Bolus set up menus involve variable information as well as fixed information. The values may be variable, but the main menu items (title of variables, etc.) will stay the same. Variable menus contain information that is completely variable, e.g., bolus history screen. Variable data is sent at the time of the screen display, and there is generally no fixed text. What is displayed in variable menus depend on what bolus action the user selects. The history screens resemble the menu screens in that the user cannot select and input any information with the history screen. Data entry screens, on the other hand, include multiple fields on a screen and can accept data selection and input by the user. - Different units may need to be switched dynamically in depending on how the type of entry is communicated. The screens may also need to be able to display minimum and maximum values as well as time increments, to ensure precision of the display. The rules for this translation will be defined in the infusion pump device. Likewise, for a dual-wave bolus, there must be defined how the values interlock. Sensor high and low BG values also need to be interlocked (in some embodiments, these two values will be displayed in the same screen).
- In one embodiment, communication between the infusion system components takes place when the user presses one or more keys to send data to the infusion pump device and, in response, the infusion pump device can relay to the controller device to instruct on what to display. Alternatively, the user may input data through scrolling down menus and selecting options. When the user prompts, the controller device, for example by pressing an “ACT” button, the controller device will then tell the infusion pump what to do, e.g., deliver fluid to the user.
- In its most simplest form, the controller device is a display only, used to show a BG value and/or graph. In another simple form, the controller device embodies only a virtual keypad that may mimic exactly the buttons on the infusion device. When the user presses a key on the controller device, the controller device tells the infusion device what button was pressed—and the infusion device acts as if the button was pressed on the infusion device itself. Each component of the infusion system may be of different degrees of sophistication. For example, the controller device can range from a simple key fob with limited capabilities and with, for example, one or two keys to a complex device with memory, many keys and advanced graphing options. In a complex form, the controller device may embody all or substantially all of the intelligence that is present in the infusion device. In this form, the controller device could do all calculations, graphing functions, and other data input, output, and manipulation at the controller device. The controller device would then send data to the infusion device indicating what the controller device had done so that the infusion device could be put into the same state as the controller. It is possible for the controller device to have many different degrees of computing intelligence, so that few, none, many, or all computing may be done at the controller device. How much intelligence will be in the controller device may depend on battery life, size requirements, and so forth.
- In further embodiments, the processor of the controller device has unique identification information, and the communication transmitted from the controller device to the infusion device further includes the unique identification information of the controller device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device. In yet further embodiments, the processor of the infusion device has unique identification information, and the communication transmitted from the controller device to the infusion device further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
- Additionally, both the controller device and the BG meter may communicate over wireless networks. Some examples include RF, IR, Bluetooth, spread spectrum communication, and frequency hopping communication. In further embodiments, there may be a “Listen Before Talk” scheme where the system selects the cleanest of allotted channels through which to communicate. Further examples include giving the controller device cellular telephone or pager capabilities. In the alternative, the communication may be wired, such as in hospital use. In a wired embodiment, there may be a tether physically connecting the infusion pump device to the controller device and/or BG meter. In yet another alternative, the controller device and the infusion pump device could be both wired and wireless—when wired, the two components communicate by wire, and when disconnected, the two components could operate through wireless communication.
- In another wireless example, if the user has access to a computer network or phone connection, the user can open communication via the internet to obtain communications from, and send communications to, a nurse, parent, or anyone so desired. As discussed above, a transceiver may be used to facilitate data transfer between the PC and the infusion pump device. Such a communication may also be used by a party, other than the user, to control, suspend, and/or clear alarms. This embodiment could be very useful for a parent to monitor the infusion system of a child, or for a physician to monitor the infusion system of a patient. The transceiver may allow patients at home or clinicians in a hospital setting to communicate with the various components of the infusion system via RF telemetry. The transceiver may be used to download device information from the pump and sent to the PC when the transceiver is connected in to the serial port of the PC. In embodiments, the transceiver may derive its power from the PC when the two are connected. In this way, the transceiver conveniently does not require a separate power source. In another embodiment, a cellular phone may be used as a conduit for remote monitoring and programming. In yet other embodiments, the controller device with a BG meter may also act as a transceiver, which would eliminate an extra component.
- In further embodiments, the controller device communication system is capable of being deactivated and reactivated. The controller device may include input devices, such as keys, buttons, and the like, for inputting commands, and the communication system of the controller device is capable of being deactivated in response to a first command from the user input device and being reactivated in response to a second command from the user input device. Alternatively, the communication system of the controller device may be automatically reactivated after a predetermined amount of time has elapsed or at a predetermined time of day.
- In an embodiment of the present invention, the processor of the infusion device uses power cycling such that power is periodically supplied to the communication system of the infusion device until a communication is received from the controller device. When a communication is received from the controller device, the processor of the infusion device discontinues using power cycling so that the power is continuously supplied to the infusion device communication system. The infusion device processor may then resume using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from a BG meter communication system.
- In yet another embodiment, the infusion system may include a bedside monitor. The monitor could communicate through the same avenues as the BG meter, the controller device, and the infusion pump device. The monitor could be used, as described above, to remotely alarm people other than the user, such as for example, parents, physicians, nurses, and the like. This would provide an extra layer of monitoring for the user, especially when the user is alone. In further embodiments, the system may be set up so that multiple devices are placed around the house. This would provide easy access to monitor the diabetic. Additionally, the parent will be able to obtain data to monitor a child user at home and when the parent is away. Such home monitors could be set to any mode preferred, for example, flashing lights, warning sounds like beeping, vibration, and the like. Other features may include a function that allows the remote user (parent, physician, nurse, etc.) to change and/or deliver a bolus from remote sites.
- In an alternative, the controller device may be configured so as to have cellular telephone capabilities. The cellular network could provide a conduit for remote monitoring and programming. Additionally, the cellular network could be used to notify parents, physicians, or emergency services of alarms or alert states. A button may be included on the controller device and/or the infusion device to automatically alert a parent, physician, or emergency services when pressed. For example, a monitoring device may be built directly into a patient's cellular telephone so that in the case of a hypoglycemic event, an alarm or connection may be made to emergency services via the cellular telephone. In a further embodiment, GPS technology may also be built into the cellular telephone to allow easy location of the patient. Alternatively, GPS technology may be included in the controller device without cellular telephone technology. In other embodiments, the GPS technology may also be built into the infusion pump, BG meter or controller device.
- The infusion system may be part of a closed-loop system, such as an implantable infusion system with a sensor system or an external infusion device with a sensor system. In such a system, there may be included safety nets, such as alarms and automatic shut-offs.
- The alarms may be customized to specific user needs. The alarm may be set to flashing lights for the hearing impaired, or warning sounds and/or vibration for the vision impaired. There could further be included headphones that can plug into the controller device for vision impaired to instruct the user on what to do in the case that an alarm goes off. The headphones could also be plugged into a MPEG player or the like. To avoid having the pump broadcast information, the alarms may be handled in a way where the user presses a button on the controller device. Alarms could also be included on the pump. There may further be included a turn-off option where, if there is a need to communicate with the controller, the user can choose a selection to turn off the controller. In further embodiments, there may be included a feature in any of the devices including an alarm where when the device has sounded an alarm for a period of time and the user has not responded, the alarm will switch to a vibrate mode and/or will attempt to signal companion devices in the system to alarm the user.
- It is noted that some users can be expected to have somewhat diminished visual and tactile abilities due to the complications from diabetes or other conditions. Thus, the display and buttons or other input devices may be configured and adapted to the needs of a user with diminished visual and tactile abilities. In alternative embodiments, the high level module (and/or the low level module) may communicate to the user by audio signals, such as beeps, speech or the like.
- Other display settings may be customizable, including, but not limited to, the background, sounds, fonts, and wallpaper. There may be a children's mode, with limited features available so that a child cannot dispense too much medication at once. Different display features may be included in the module and/or may be downloaded from a computer. The high level module may have a memory with which to store customized settings or pump control. The memory may be of any type that is known in the art, such as a volatile or non-volatile memory. Both a volatile and non-volatile memory may be used, which can speed up operation of the pump. As an example, non-volatile memories that could be used in the invention include flash memories, thumb drives and/or memory sticks such as USB thumb drives, removable hard drives, and optical drives.
- In some embodiments, the language that the controller device operates in may comprise several different languages, ranging from 1 language to about 40 languages and potentially more. To set language, data must be first initialized to modify the phrases and detail font that may be significantly different in one language as compared to another language. For example, some languages, such as Chinese, are read in vertical columns, from the right to the left, and thus, needs to be displayed in such manner. One way to overcome this complication in using different languages is to have fonts built into the infusion pump device. Because fonts are now described in pen strokes (true-type fonts), rather than in pixels (bit-by-bit) this allows the infusion pump device to determine out how to display the different fonts. Another option could involve uploading the fonts in strings from various sources, such as the internet.
- If so desired, a food library may be downloaded from a PC, or from the internet via a PC. In the food library, each food item will have some information associated with it, for example, carbohydrate count, fat count, proteins, serving size, and the like. The food library may be built directly into the infusion pump device, or it may be downloaded from remote sources, as discussed above. For one example, the food library may be downloaded through a transceiver embodied by the user's cellular telephone. Other options may include eliminating the need to bypass the transceiver every time a food item is selected, such as, downloading the food items from the PC and storing it until use. The food library may also be input directly into the controller device rather than the infusion pump device. If the food library is contained in the infusion pump device, an associated food library menu could be dynamic. The user could select from different layers of the food library the items consumer or about to be consumed and the infusion pump device could calculate the appropriate amount of insulin to be delivered. Variable data could be included for a small food library with less than 50 food items. For example, there could be variable data for a food library dedicated to breakfast foods only. There could be a “breakfast” key or icon on the controller device that the user can select. There may also be “lunch” and “dinner” and “snack” icons.
- Communications between the system components may be performed in a variety of manners. In an embodiment using RF options, there could be employed a single frequency or a “spread spectrum” where a large range of RFs can be used to relay the communication. In another embodiment, changing frequencies can be used so as to pick up whatever frequency is present. This is known as “frequency hopping,” where the frequency changes every millisecond or so to take advantage of all, or substantially all, frequencies available. In some cases, frequency hopping allows the system to find frequencies that are not being used by other nearby systems and thus avoid interference. In addition, a system may operate in a manner where each component-to-component communication is on a different frequency, or where the delay for each communication is different. Other types of RF, that are not described, may also be used for communication, such as, translation frequency.
- According to yet another embodiment of the present invention, an infusion system includes a controller device, with a controller device display, and an infusion device, with an infusion device display, and a method for infusing a fluid into a body of a user is provided. The method includes the steps of: receiving data communication from a user, transmitting with the controller device the communication including data to an infusion device, receiving with the infusion device the communication, and displaying with the controller device display information regarding the fluid delivery, where the display on the controller device display shows information according to instructions or communications sent to the controller device from the infusion device. At any moment, the display of the infusion device may correspond with what is displayed on the infusion device display. The method may further include the step of displaying a trends and graphs. Additionally, the method may include the step of inputting an estimate of a material to be ingested by the user, and the estimated amount of fluid to be infused into the body of the user is calculated further based upon the inputted estimate of the material to be ingested by the user.
- Although the above description has been focused on use of a controller device with an infusion device, it is appreciated that a controller device as described herein could be used with any number of therapy/diagnostic devices. For example, in any case where a therapy/diagnostic device is tethered to the body, at least partially implanted in the body, or otherwise inconvenient for the user to manipulate while therapy or diagnosis is being performed, a controller device may be used that can send commands to the therapy/diagnosis device and/or mimic the display on the therapy/diagnosis device. Therapies other than infusion of fluids could include electrical therapy, such as electrical therapy for the brain and for conditions such as epilepsy. Diagnostics could include any number of diagnostics, such as information from cardiac and other sensors.
- Electrical therapy devices include neurostimulation devices for epilepsy, similar devices for pain management, etc. In addition, there are electro-acupuncture devices, where a needle is inserted into the body much like acupuncture, but additional therapy is delivered by electrical impulses. In certain embodiments, the structure of an electrical therapy device may include a needle that is inserted into appropriate areas of the body. The architecture would be similar to that of the devices described above. The patient/user would use the controller device to deliver “dosages” of electrical impulses to alleviate pain and manage neurological symptoms on demand such as twitching, uncontrolled movement of limbs, spasms, and so forth.
- In further embodiments, devices such as those used in physical therapy clinics could be adapted for individual use. For example, a patch or other device placed on the body could be activated by the controller device to delivery said therapy, be it ultrasound, heat or some other media. The architecture for these devices could be similar to the architecture of the devices already described, where a physiological characteristic sensor or infusion device is replaced by a therapy delivering device/mechanism.
- A portable electronic device may receive power from a removable main battery and/or a backup battery. In this embodiment of the invention, if a new removable main battery is inserted into a portable electronic device, an internal backup battery may be charged to full capacity. After the internal backup battery is charged to full capacity, the internal backup battery is disconnected. After the removable main battery has been drained of most of its energy, the main battery may be switched out of the circuit and the internal backup battery is used to supply power to the device. At this time, an indication of a low battery voltage is issued. A super capacitor (super cap), charged by the backup battery, may have enough energy storage to handle the peak loads that a rechargeable internal battery cannot handle directly. This method allows the use of any type of removable battery (alkaline, lithium, or rechargeable) and partially drained batteries. Depending on the use, the backup battery should allow the device to operate for a known amount of time after the removable main battery has been drained or removed. A controller would measure the charge states and operate the control switches for the removable main battery and internal backup battery.
- Although a controller is identified above as performing action for measuring charge states and operating control switches, a microcontroller, logic, control circuitry, or application specific integrated circuits (ASICs) may be utilized to perform the same actions or other actions below described as being performed by the processor. Further, a processor, which loads operating software from a location outside of the processor may also perform the actions described above and below that are controlled by the controller. From this point forward, the term controller is utilized but a microcontroller, logic, control circuitry, ASIC(s), or a processor may be utilized to control the same actions.
- The portable electronic device may be a portable personal medical device, such as an insulin pump, a glucose sensor, a transmitter, a pacemaker, or any type of medical monitor. In addition, the portable electronic device may be a cellular phone, a personal digital assistant, a digital music player, or a Blackberry or Treo type device. The present invention applies to any portable electronic device that is powered or can be powered by a removable battery and a backup battery.
-
FIG. 9 illustrates a method to provide full functioning power to a portable electronic device after a main battery has reached a low voltage threshold according to an embodiment of the present invention. In an embodiment of the invention, a main battery is inserted 905 into a power circuit for the portable electronic device. The main battery may be an alkaline battery, a lithium ion battery, or a rechargeable battery. NiCad, NMH, and Lithium batteries are examples of rechargeable batteries. - A main battery detection circuit in the portable electronic device may detect 910 that the main battery has been inserted into a power circuit and may transmit 910 a power detection signal to a controller or processor of the portable electronic device indicating that a main battery has been detected in the portable electronic device. In an embodiment of the invention, a polarity detection circuit may detect if the battery has been inserted incorrectly. In this embodiment of the invention, the portable electronic device may issue an error message instructing that the battery be placed in the portable electronic device correctly. In an embodiment of the invention, the portable electronic device may compensate for the incorrectly inserted battery. This may occur by a circuit or module in the portable electronic device reversing the coupling of the battery power into a power circuit of the portable electronic device.
- In an embodiment of the invention, the controller may receive the battery detection signal. After receiving the battery detection signal, the controller may transmit a charge signal or a charging
voltage 915 to the backup battery. In other words, the backup battery is being charged through an output of the controller. Accordingly, the backup battery is being charged indirectly by the main battery because the main battery is supplying power to the controller, which in turn supplies power to the backup battery. - In an embodiment of the invention, the controller may monitor charging 915 of the backup battery. Once, the backup battery is determined to be charged, the controller may disable charging 920 of the backup battery. In an embodiment of the invention, the controller may determine that a backup battery is charged based on a time measurement or calculation. In other words, the controller may wait a specific period of time (e.g., 24 hours, 48 hours, 12 hours) and then cease to send a charging signal to the battery. In an embodiment of the invention, the controller may monitor a voltage or current of a backup battery. Once the backup battery reaches a charging threshold voltage or current, the controller may cease to supply power to the backup battery. In an embodiment of the invention, the controller may monitor a voltage of the backup battery and after a specific period of time, e.g., 24 hours, 30 hours, or 40 hours, even if the backup battery voltage is not measured to be above the threshold, the controller may stop providing power to the backup battery. In an embodiment of the invention, the charging of the backup battery may take one day or two days. The time required for charging of the backup battery depends on how long the backup battery is utilized for powering the portable electronic device. The charging of the backup battery may, for example, utilize between 2-5% of the main battery's voltage. Under certain operating conditions, the charging of the battery may occur at the time when the main battery is providing power for the portable electronic device.
- The main battery is monitored 925 to determine if the main battery voltage has decreased or has been drained and if a low voltage battery threshold has been met. In an embodiment of the invention, the controller monitors a voltage of the main battery and determines whether or not the main battery voltage has reached a low main battery threshold. In one embodiment of the invention, the low main battery threshold may be 0.8 volts. The low battery threshold voltage can be 0.8 volts because it allows a larger percentage of the battery energy to be utilized as compared to prior art systems where the low battery threshold voltage is approximately 1.1 volts. In other words, in previous portable electronic device systems, a message would be transmitted indicating low battery at 1.1 volts (and in some cases disabling the device). This message would be sent out although as much as ⅓rd of the battery energy still remained. Illustratively, the low battery threshold voltage may be any value less than 1.0 volt. This is significant because the portable electronic device can run to a lower main battery voltage because a backup battery is present within the system and will provide power to maintain full functionality of the portable electronic device after the main battery has been drained. In an embodiment of the invention, the backup battery may provide the power or voltage for a known minimum time. This results in more energy of the main battery being utilized before the battery has to be replaced or recharged. For example, in prior art systems, about two-thirds of the battery's energy was typically utilized, while with the invention, greater than 95% of the battery's energy may be utilized. In an embodiment of the invention, the low battery threshold can be set to a specific level or to the same level for all of the different types of batteries, e.g., alkaline, rechargeable, or lithium. Illustratively, the low battery threshold voltage for the main battery may be 0.8 volts or any other voltage less than 1.0 volt.
- If the main battery is still outputting a voltage above or greater than the low voltage threshold, a predetermined amount of time is counted 930, and then the main battery is monitored again to determine if the main battery voltage has decreased below the low voltage threshold. In an embodiment of the invention, if the controller determines that the main battery is operating above the low voltage threshold, the controller may wait a specified amount of time, e.g., 1 second, 5 seconds, 15 seconds, 1 minute, or 5 minutes, and may again monitor the voltage of the main battery after the specified amount of time has elapsed.
- If the main battery is not operating above the low voltage threshold, the controller transmits 935 a disconnect signal to disconnect the main battery from the powering circuit of the portable electronic device. In an embodiment of the invention, the controller may transmit a signal to a switch to close, which results in the main battery being coupled to ground. At this time, the main battery is not providing power for the portable electronic device. Under these operating conditions, the removable main battery can be recharged or replaced.
- At approximately the same time or alternatively, in the same timeframe, if the main battery voltage has decreased below the low voltage threshold, the controller transmits 940 a connection signal to connect the backup battery to the powering circuit of the portable electronic device. In other words, the controller transmits a signal to connect the backup battery. In an embodiment of the invention, the controller or processor may transmit a signal to close a switch to couple the battery into a circuit for powering the portable electronic device. In an embodiment of the invention, the backup battery may be placed into circuit such that the backup battery is in parallel with a capacitor (which may be referred to as a super capacitor or supercap). In an embodiment of the invention, the capacitor or super capacitor may be charged up by the backup battery and may provide power to a boost converter. In an embodiment of the invention, the main battery is also in parallel with the supercap, and the supercap may be charged by the main battery. In an embodiment of the invention, after the backup battery is switched into powering the portable electronic device, the controller may transmit a message indicating an amount of time for which the backup battery is capable of powering the portable electronic device. This may be a minimum time that the backup battery can provide time for the portable electronic device based on a maximum potential current draw of the portable electronic device.
- The backup battery itself is not utilized to power the electronic circuits and components because the backup battery does not provide smooth enough power for the electronic circuits and components of the portable electronic device. In other words, there may be spikes or ripples within the voltage provided by the backup battery. This may also be true with the main battery because the main battery may not provide smooth or stable power for the electronic circuits and components of the portable electronic device. The boost converter provides power for a large number of electronic components (e.g., processors, motors, display modules) in the portable electronic device. The backup battery supplies power to the supercap to allow for full functionality of the portable electronic device. In other words, all of the operating features of the portable electronic device can be utilized even when the portable electronic device is being powered by a backup battery. The powering of full functionality of the portable electronic device in the present invention is unlike many prior art systems where the backup battery provides power only for a run-time clock and for storing system settings in a CMOS memory. In an embodiment of the invention, the backup battery is able to provide full-functioning power to the portable electronic device for a predetermined time, (e.g., 24 hours when normal battery life for a battery is 30 days). The battery life is dependent on the average energy usage by the portable electronic device. In another embodiment of the invention, the backup battery provides power to allow for full functionality of the portable electronic device for 48 hours (e.g., this is dependent upon the average energy use of the device). Longer timeframes, such as 24 or 48 hours, allow a user of the portable electronics device to continue to operate the portable electronic device with a sense that the device will not lose power and still have time to find a replacement main battery and/or to recharge the main battery. This is important for persons who utilize portable electronic devices in remote areas where a new battery or recharging for a rechargeable battery is not available. It is also important for people who utilize portable electronic devices in medical applications where constant power to the portable electronic device is essential along with knowing approximately how long the portable electronic device can operate utilizing the backup battery.
- After the backup battery has been connected to power the portable electronic device, the controller continues to monitor 950 the main battery to determine if a new or recharged main battery is connected to the charging circuit of the portable electronic device. Once the controller determines a sufficiently charged or new main battery has been installed, the controller transmits 960 a signal to connect the main battery to the charging circuit. The controller also transmits 965 a signal to disconnect the backup battery from providing power to the portable electronic device. The controller also begins to charge 915 the backup battery, as is described above. The controller also starts the monitoring of the main battery voltage.
-
FIG. 10 illustrates a block diagram of a powering subsystem for a portable electronic device according to an embodiment of the present invention. The poweringsubsystem 1000 provides full functional power to the portable electronic device whether the main battery is providing the power or the backup battery is providing the power. This is unlike other powering subsystems for devices utilizing batteries where a backup battery only provides power to support a run-time clock and/or limited functionality for the portable electronic device. In an embodiment of the invention illustrated inFIG. 10 , the powering circuit includes amain battery 1010, a main batteryvoltage measurement circuit 1020, a mainbattery connection circuit 1030, a mainbattery detection circuit 1040, acapacitor 1050, avoltage converter 1060, abackup battery 1070, acontroller 1075, a backupbattery connection circuit 1080, a backupbattery monitoring circuit 1090, and acharging circuit 1095. - As the portable electronic device is utilized, the
main battery 1010 is being drained because it is supplying the voltage and power for the portable electronic device. A mainbattery detection circuit 1040 monitors whether amain battery 1010 is installed in the portable electronic device. If the main battery is installed within the portable electronic device, the mainbattery detection circuit 1040 transmits a signal to thecontroller 1075 identifying that themain battery 1010 is installed. In an embodiment of the invention, aswitch 1041 may be opened on a periodic basis, and a voltage may be measured across aresistor 1042 to verify that a voltage is being supplied by the mainremovable battery 1010. If a voltage is detected, the main battery detection signal is transmitted to thecontroller 1075. - Under certain operating conditions, if the
main battery 1010 is determined to be installed, thecontroller 1075 transmits a signal request to the main batteryvoltage measurement circuit 1020 to obtain a voltage reading of the voltage supplied by themain battery 1010. Under certain other operating conditions, thecontroller 1075 may wait to receive a voltage level reading from the main batteryvoltage measurement circuit 1020. In an embodiment of the invention, the main batteryvoltage measurement circuit 1020 is measuring the voltage across the super capacitor (supercap) 1050. In an embodiment of the invention, the main batteryvoltage measurement circuit 1020 is measuring the voltage supplied by themain battery 1010. - The
controller 1075, after receipt of the voltage level of themain battery 1010, compares the received voltage against a low voltage threshold level previously stored in thecontroller 1075. In an embodiment of the invention, the low voltage threshold is 0.8 volts. Illustratively, the low voltage threshold may be any voltage less than 1.0 volt, such as 0.5, 0.6, 0.72, or 0.93 volts. The low voltage threshold may be other voltages also. This is a decrease from previous low voltage thresholds for batteries, which ranged from 1.08 to 1.16 and allows more of the energy of the battery to be utilized for powering the portable electronic device. This results in the portable electric device being able to utilize a larger percentage of the battery energy, e.g., greater than 95% of the battery energy. This allows the user of the portable electronic device to spend less on batteries and also have a predictable time that the backup battery provides power to the portable electronic device. - Under normal operation of a portable electronic device, the
main battery 1010 charges up thecapacitor 1050. Thecapacitor 1050 supplies a voltage to thevoltage converter 1060. Themain battery 1010 cannot directly provide the power to the components of the portable electronic device, e.g., processors, controllers, or motors, because of the fluctuating characteristics of battery supplied voltage. Thevoltage converter 1060 steps up the voltage to a larger value and provides a plurality of voltages to other systems and components of the portable electronic device. For example, as illustrated inFIG. 10 , thevoltage converter 1060 provides a voltage to thecontroller 1075. In addition, thevoltage converter 1060 provides voltages to a processor (e.g., like a processor utilized to perform calculations), a display system (for driving a display of the portable electronic device, and a motor (for driving mechanical systems within the portable electronic device). Illustratively, thevoltage converter 1060 may receive an input of 0.8 to 2 volts, may step up or boost this voltage and may supply, for example, 3.0 volts, 3.3 volts, and 5.0 volts to thecontroller 1075 and other systems within the portable electronic device. In an embodiment of the invention, the portable electronic device is an insulin infusion pump. When the portable electronic device is an insulin pump, the other systems being provided voltage (or power) from thevoltage converter 1060 are adisplay subsystem 1002 for driving a display of the infusion pump, acalculation processor 1004 for calculating a delivery amount of insulin based on input from a user of the infusion pump, and amotor 1006, for actually driving the delivery of the insulin from the infusion pump to the subject user. - After the
main battery 1010 has been inserted, thecontroller 1075 receives an operating voltage from thevoltage converter 1060 under normal operation. Thecontroller 1075 may also transmit a signal to charge thebackup battery 1070. In an embodiment of the invention, thecontroller 1075 transmits the signal to acharging circuit 1095 which in turn transmits a charging voltage to thebackup battery 1070. This allow abackup battery 1070 to indirectly receive a charge voltage from themain battery 1010 to receive its power. Under certain operating conditions, thecontroller 1075 may determine themain battery 1010 has enough voltage to operate, but does not have enough voltage to charge thebackup battery 1070. In this embodiment of the invention, thecontroller 1075 may issue an error message to the user indicating that there is not enough power in the main battery to charge the backup battery and therefore the backup battery is not being charged. - If the
controller 1075 determines that the voltage level reading from the main battery 1010 (measured by the main battery voltage measurement circuit 1020) is drained below the low battery threshold voltage, thecontroller 1075 transmits a disconnect signal to the mainbattery connection circuit 1030 to disconnect the main battery from the poweringcircuit 1000. In an embodiment of the invention, thecontroller 1075 transmits a signal to a mainbattery connection circuit 1030 to uncouple themain battery 1010 from ground, which disconnects themain battery 1010 from providing power to the capacitor 1050 (and thus thepower converter 1060 and microcontroller 1075). This does not disconnect power to the portable electronic device because thecapacitor 1050 is stored with energy which is utilized and supplied to theconverter 1060. Under certain operating conditions, this is also true when switching from backup battery power to main battery power. - In an embodiment of the invention, the
controller 1075 transmits a connection signal to the backupbattery connection circuit 1080 to make thebackup battery 1070 the power supply for thepower subsystem 1000 of the portable electronic device. In an embodiment of the invention, thecontroller 1075 transmits the backup battery connection signal to aswitch 1080 that couples thebackup battery 1070 to the capacitor 1050 (e.g., super capacitor) to charge thecapacitor 1050. After the backup battery charges up thecapacitor 1050, thecapacitor 1050 provides a voltage to theconverter 1060 which in turn provides operating voltages to the controller orprocessor 1075. Theconverter 1060 may also provide power to other devices such as aprocessor 1002,display system 1004, andmotor 1006. Thebackup battery 1070 continues powering the subsystems of the portable electronic device for a minimum established period of time, e.g., 24, 36, or 48 hours, without a user of the portable electronic device worrying that the portable electronic device may fail. Thebackup battery 1070 may provide power for more than the minimum established period of time because the battery life is dependent upon the usage of the portable electronic device. - In an embodiment of the invention, the
controller 1075 monitors the charge or voltage level ofbackup battery 1070 by measuring the voltage of thebackup battery 1070. In an embodiment of the invention, a backup batteryvoltage detection circuit 1090 measures the voltage level of thebackup battery 1070 and transmits a voltage level signal to thecontroller 1075. Thecontroller 1075 receives the backup battery voltage level and compares it to a backup battery low threshold voltage. If the backup battery voltage level is below the backup battery low threshold voltage, thecontroller 1075 may transmit a message to a user that it is shutting down the portable electronic device or risk operational failure of the portable electronic device. This occurs only if a newmain battery 1010 has not been inserted after the portable electronic device switched to being powered by the backup battery. - If the new or recharged
main battery 1010 is inserted into the poweringsubsystem 1000, the mainbattery detection circuit 1040 determines that the new or rechargedmain battery 1010 has been placed into the poweringsubsystem 1000. If the mainbattery detection circuit 1040 detects the new main or rechargedmain battery 1010, a battery detection signal is transmitted to thecontroller 1075. Thecontroller 1075 receives the battery detection signal and transmits the connection signal to the mainbattery connection circuit 1030 to place themain battery 1010 in parallel with thesuper capacitor 1050 to provide functional power to the portable electronic device (through the power converter 1060). Thecontroller 1075 also transmits a backup battery connection signal to disconnect thebackup battery 1070 from charging up thesuper capacitor 1050. In other words, thebackup battery 1070 is no longer providing the power for the portable electronic device. After thebackup battery 1070 has been disconnected from providing power to thesuper capacitor 1050, thecontroller 1075 also charges up thebackup battery 1070, either directly or through the backupbattery charging circuit 1095. - While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
- The presently disclosed embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than the foregoing description. All changes that come within the meaning of and range of equivalency of the claims are intended to be embraced therein.
Claims (26)
1. A method of providing backup power to a portable electronic device having a main battery and a backup battery, the method comprising:
detecting whether the main battery has been inserted into the portable electronic device and transmitting a detection signal to a controller if the main battery is detected;
after the main battery has been detected, coupling a voltage from the main battery to a power converter;
providing an operating voltage from the power converter to the controller;
charging the backup battery utilizing a signal transmitted from the controller, so as to charge the backup battery by the main battery;
monitoring a battery level of the backup battery and disabling the charging of the backup battery if the charging level of the backup battery has been exceeded;
monitoring a battery level of the main battery and generating a first signal to cause the main battery to be disconnected if the battery level of the main battery is less than a low-battery threshold value; and
generating a second signal to cause the backup battery to provide power for the portable electronic device.
2. The method of claim 1 , wherein charging of the backup battery is automatically initiated upon detection of the main battery.
3. The method of claim 1 , wherein the backup battery provides power for operating the portable electronic device with full feature functionality for a period of at least 24 hours.
4. The method of claim 1 , wherein the low-battery threshold value is less than 1.0 volt.
5. The method of claim 1 , wherein the battery level of the main battery and the low-battery threshold are both values of a current supplied by the main battery.
6. The method of claim 1 , wherein the generation of the first signal and the second signal occur substantially simultaneously.
7. The method of claim 1 , wherein the portable electronic device is an insulin pump.
8. The method of claim 1 , wherein a capacitor is coupled between the main battery and the power converter, the capacitor receives the voltage from the main battery, and provides the voltage to the power converter.
9. A program code storage device, comprising:
program code storage media; and
machine-readable program code, stored on the program code storage media, the machine-readable program code including instructions, which when executed cause a controller for a portable electronic device having a main battery and a backup battery to:
receive a main battery detection signal indicating that the main battery of the portable electronic device is present within a powering circuit of the portable electronic device;
receive an operating level of the backup battery of the portable electronic device;
upon receipt of the main battery detection signal, transmit a signal to a backup battery charging circuit to charge the backup battery by the main battery if the backup battery's operating level is below a backup battery charging threshold;
receive a charging level of the backup battery and stop transmitting the signal to the charging circuit if the charging level of the backup battery is above the charging threshold;
receive a main battery voltage reading and compare the main battery voltage reading against a main battery low voltage threshold;
if the main battery voltage reading is less than or equal to the main battery low voltage threshold, transmit a main battery disconnect signal to a switching device to disconnect the main battery from providing power to the controller; and
transmit a backup battery connect signal to a switching device to connect the backup battery of the portable electronic device to provide power to the controller.
10. The program code storage device of claim 9 , including instructions, which when executed, cause the controller to transmit a message to a display of the portable electronic device indicating a minimum time for which the backup battery can provide power for the portable electronic device.
11. The program code storage device of claim 9 , including instructions, which when executed, cause the controller to automatically transmit the signal to the backup battery charging circuit to charge the backup battery by the main battery if the backup battery's operating level is below the backup battery charging threshold.
12. A powering subassembly for a portable insulin pump comprising:
a main battery to provide a main voltage to the insulin pump;
a converter to receive the main voltage and to increase the main voltage to at least one operating voltage;
a capacitor coupled between the main battery and the converter, wherein the capacitor is charged up by the main battery and provides a smoother main voltage to the converter;
a backup battery configured to be charged by the main battery and to provide a backup voltage to the insulin pump; and
a controller to receive the operating voltage from the converter, to monitor a voltage level of the main battery, to compare the monitored voltage level of the main battery to a main battery low voltage threshold, to transmit a disconnect signal to prevent the main battery from providing the main voltage to the converter if the monitored voltage level is less than or equal to the main battery low voltage threshold, to transmit a connection signal to the backup battery to cause the backup battery to provide a backup voltage to the converter, and to receive an operating level of the backup battery and transmit a signal to a charging device to charge the backup battery by the main battery if the operating level of the backup battery is below a charging threshold.
13. The powering subassembly according to claim 12 , wherein the backup battery provides power for operating the insulin pump with full feature functionality for a period of at least 24 hours.
14. The powering subassembly according to claim 12 , wherein, if the operating level of the backup battery is below the charging threshold, the controller automatically transmits the signal to the charging device to charge the backup battery by the main battery.
15. The powering subassembly according to claim 12 , further including a switching device to uncouple the main battery from a reference ground after receiving the disconnect signal.
16. The powering subassembly according to claim 12 , wherein the controller monitors a charging level of the backup battery and discontinues transmission of the signal to the charging device if the charging level of the backup battery is above the charging threshold.
17. The powering subassembly of claim 12 , wherein the main battery low voltage threshold is less than 0.8 volt.
18. The powering subassembly according to claim 12 , wherein at least 95% of the main battery energy is utilized before the main battery reaches a low voltage threshold.
19. The powering subassembly according to claim 12 , wherein the converter provides other operating voltages to a pump, a display, and a second processor, the second processor not being the controller.
20. A portable insulin pump, comprising:
a display to provide messages to a user; and
a powering subassembly, the powering subassembly including:
a main battery to provide a main voltage to the portable insulin pump;
a backup battery configured to be charged by the main battery and to provide a backup voltage to the portable insulin pump;
a capacitor, coupled to one of the main battery and the backup battery, and capable of being coupled to both the main battery and the backup battery, to receive either the main voltage or the backup voltage, and to transfer the received voltage;
a converter to receive the received voltage from the capacitor and to generate at least one operating voltage; and
a controller to receive the at least one operating voltage from the converter, to monitor the main voltage of the main battery, to compare the monitored level of the main battery to a main battery low voltage threshold, to transmit a disconnect signal to prevent the main voltage from the main battery from being coupled to the capacitor if the monitored level of the main battery is less than or equal to the main battery low voltage threshold, to transmit a signal to a charging device to charge the backup battery by the main battery if the backup voltage of the backup battery is below a charging threshold, and to transmit a connect signal to couple the backup voltage from the backup battery to the capacitor if the monitored level of the main battery is less than or equal to the main battery low voltage threshold.
21. The insulin pump of claim 20 , wherein the backup battery provides power for operating the insulin pump with full feature functionality for a period of at least 24 hours.
22. The insulin pump of claim 20 , wherein, if the operating level of the backup battery is below the charging threshold, the controller automatically transmits the signal to the charging device to charge the backup battery by the main battery.
23. The insulin pump of claim 20 , wherein the converter provides an operating voltage for the display.
24. The insulin pump of claim 20 , wherein the main battery can be a removable rechargeable battery which can be recharged by household current.
25. The insulin pump of claim 20 , wherein the main battery low voltage threshold is less than 1.0 volt.
26. The insulin pump of claim 20 , wherein at least 95% of the main battery energy is utilized before the main battery reaches a low voltage threshold.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/332,249 US20120091813A1 (en) | 2005-08-16 | 2011-12-20 | Method and apparatus for predicting end of battery life |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/204,667 US20070060870A1 (en) | 2005-08-16 | 2005-08-16 | Controller device for an infusion pump |
US11/447,637 US7737581B2 (en) | 2005-08-16 | 2006-06-06 | Method and apparatus for predicting end of battery life |
US12/768,424 US8106534B2 (en) | 2005-08-16 | 2010-04-27 | Method and apparatus for predicting end of battery life |
US13/332,249 US20120091813A1 (en) | 2005-08-16 | 2011-12-20 | Method and apparatus for predicting end of battery life |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/768,424 Continuation US8106534B2 (en) | 2005-08-16 | 2010-04-27 | Method and apparatus for predicting end of battery life |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120091813A1 true US20120091813A1 (en) | 2012-04-19 |
Family
ID=38832333
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/447,637 Active 2027-05-02 US7737581B2 (en) | 2005-08-16 | 2006-06-06 | Method and apparatus for predicting end of battery life |
US12/768,424 Expired - Fee Related US8106534B2 (en) | 2005-08-16 | 2010-04-27 | Method and apparatus for predicting end of battery life |
US13/332,249 Abandoned US20120091813A1 (en) | 2005-08-16 | 2011-12-20 | Method and apparatus for predicting end of battery life |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/447,637 Active 2027-05-02 US7737581B2 (en) | 2005-08-16 | 2006-06-06 | Method and apparatus for predicting end of battery life |
US12/768,424 Expired - Fee Related US8106534B2 (en) | 2005-08-16 | 2010-04-27 | Method and apparatus for predicting end of battery life |
Country Status (5)
Country | Link |
---|---|
US (3) | US7737581B2 (en) |
EP (1) | EP2033068B1 (en) |
JP (1) | JP5264715B2 (en) |
CA (2) | CA2654193C (en) |
WO (1) | WO2007145951A2 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130148283A1 (en) * | 2011-08-05 | 2013-06-13 | Qualcomm Incorporated | Systems and methods for remotely monitoring or controlling a battery |
US20140139114A1 (en) * | 2011-11-21 | 2014-05-22 | Richard Jeff Garcia | Method of Adjusting Brightness By Desired Run Time |
US9101714B2 (en) | 2010-03-25 | 2015-08-11 | Seiko Epson Corporation | Fluid injection system |
US20150235058A1 (en) * | 2014-02-20 | 2015-08-20 | Samsung Electronics Co., Ltd. | Electronic apparatus and protecting method thereof |
US9242569B2 (en) | 2011-07-15 | 2016-01-26 | Mitsubishi Electric Corporation | Vehicle charge system and vehicle charge method |
US9486571B2 (en) | 2013-12-26 | 2016-11-08 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
WO2017095962A1 (en) * | 2015-11-30 | 2017-06-08 | Airwire Technologies | A backup circuitry for providing power |
US9737656B2 (en) | 2013-12-26 | 2017-08-22 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US20170328197A1 (en) * | 2016-05-13 | 2017-11-16 | Ningbo Wanyou Deepwater Energy Science & Technolog Co.,Ltd. | Data Logger, Manufacturing Method Thereof and Real-time Measurement System Thereof |
US9976551B2 (en) | 2012-12-07 | 2018-05-22 | Smiths Medical Asd, Inc. | Syringe characterization |
WO2018175030A1 (en) * | 2017-03-22 | 2018-09-27 | Intel Corporation | Mechanism to extend the peak power capability of a mobile platform |
US10357603B2 (en) | 2017-01-11 | 2019-07-23 | Tandem Diabetes Care, Inc. | Electromagnetic signal-based infusion pump control |
JP2020110605A (en) * | 2013-12-31 | 2020-07-27 | アッヴィ・インコーポレイテッド | Pump, motor, and assembly for delivery of beneficial agent |
US10790682B2 (en) | 2018-03-30 | 2020-09-29 | Intel Corporation | Hybrid power boost charging with peak power protection |
US10888655B2 (en) * | 2019-02-19 | 2021-01-12 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US11152115B2 (en) | 2013-03-15 | 2021-10-19 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
US11305057B2 (en) | 2019-03-26 | 2022-04-19 | Tandem Diabetes Care, Inc. | Method and system of operating an infusion pump with a remote control device |
US11488549B2 (en) | 2008-05-02 | 2022-11-01 | Tandem Diabetes Care, Inc. | Display for pump |
US11666704B2 (en) | 2017-07-18 | 2023-06-06 | Becton, Dickinson And Company | Administration system, delivery device, and notification device for communicating status of a medical device |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
EP2140891B1 (en) | 2001-05-18 | 2013-03-27 | DEKA Products Limited Partnership | Conduit for coupling to a fluid delivery device |
US20080172026A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a suspension bolus |
US7008403B1 (en) * | 2002-07-19 | 2006-03-07 | Cognitive Ventures Corporation | Infusion pump and method for use |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US11779476B2 (en) | 2007-02-06 | 2023-10-10 | Deka Products Limited Partnership | Arm prosthetic device |
US10426638B2 (en) | 2007-02-06 | 2019-10-01 | Deka Products Limited Partnership | Arm prosthetic device |
US9220837B2 (en) * | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
CN104069567A (en) * | 2007-03-19 | 2014-10-01 | 茵苏莱恩医药有限公司 | Drug delivery device |
WO2008114220A2 (en) * | 2007-03-19 | 2008-09-25 | Insuline Medical Ltd. | Device for drug delivery and associated connections thereto |
US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
US8513832B2 (en) | 2007-03-30 | 2013-08-20 | Ips Group Inc. | Power supply unit |
US8390244B2 (en) * | 2007-03-30 | 2013-03-05 | Nipro Healthcare Systems, Llc | Rechargeable battery backup apparatus and method for insulin pump |
EP2156348B1 (en) | 2007-05-30 | 2018-08-01 | Ascensia Diabetes Care Holdings AG | System and method for managing health data |
US8429085B2 (en) * | 2007-06-22 | 2013-04-23 | Visa U.S.A. Inc. | Financial transaction token with onboard power source |
US8287514B2 (en) | 2007-09-07 | 2012-10-16 | Asante Solutions, Inc. | Power management techniques for an infusion pump system |
KR20140129349A (en) * | 2007-12-10 | 2014-11-06 | 바이엘 헬쓰케어, 엘엘씨 | Rapid charging and power management of a battery-powered fluid analyte meter |
EP2231229A1 (en) | 2007-12-18 | 2010-09-29 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
US20090164239A1 (en) * | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
WO2009091395A1 (en) * | 2008-01-17 | 2009-07-23 | Hewlett-Packard Development Company, L.P. | Backup power system management |
MX2009000719A (en) | 2008-01-18 | 2009-08-12 | Ips Group Inc | Method and apparatus for automatic location-specific configuration management of a removable meter unit. |
US8030890B2 (en) * | 2008-02-15 | 2011-10-04 | Sony Ericsson Mobile Communications Ab | Automatic disconnect of an AC source from a converter |
US8018091B2 (en) * | 2008-03-19 | 2011-09-13 | Universal Scientific Industrial (Shanghai) Co., Ltd. | Power-mode selectable backup power supply |
US9324071B2 (en) | 2008-03-20 | 2016-04-26 | Visa U.S.A. Inc. | Powering financial transaction token with onboard power source |
US9503526B2 (en) | 2008-05-19 | 2016-11-22 | Tandem Diabetes Care, Inc. | Therapy management system |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
EP2355865A2 (en) * | 2008-09-02 | 2011-08-17 | Medingo Ltd. | Remote control for fluid dispensing device with a rechargeable power source |
US8102154B2 (en) * | 2008-09-04 | 2012-01-24 | Medtronic Minimed, Inc. | Energy source isolation and protection circuit for an electronic device |
EP2160973A1 (en) * | 2008-09-05 | 2010-03-10 | Visgeneer, Inc. | Rechargeable biosensor |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8066672B2 (en) * | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US8262616B2 (en) | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US8016789B2 (en) | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8708376B2 (en) | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
EP2355758A2 (en) | 2008-11-07 | 2011-08-17 | Insuline Medical Ltd. | Device and method for drug delivery |
US20100130263A1 (en) * | 2008-11-21 | 2010-05-27 | Edward Zhang | System and method for dual power source management |
US8090415B2 (en) * | 2008-12-12 | 2012-01-03 | Sony Ericsson Mobile Communications Ab | Intelligent battery warning system |
WO2010071972A1 (en) | 2008-12-23 | 2010-07-01 | J.J.Mackay Canada Limited | Low power wireless parking meter and parking meter network |
US20100182157A1 (en) * | 2009-01-22 | 2010-07-22 | Delphi Technologies, Inc. | Wireless battery sensor |
US8030800B1 (en) * | 2009-04-08 | 2011-10-04 | William J Terrell | Integrated power sources for mobile electronic devices |
US8154149B2 (en) * | 2009-05-01 | 2012-04-10 | General Electric Company | Method and apparatus for charging a vehicle energy storage system |
CA2921304C (en) | 2009-07-30 | 2018-06-05 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
WO2011029062A2 (en) | 2009-09-04 | 2011-03-10 | Ips Group, Inc. | Parking meter communications for remote payment with updated display |
CA2773132C (en) | 2009-09-04 | 2015-11-03 | Ips Group Inc. | Location-aware advertising to parking location users |
ATE530213T1 (en) | 2009-09-10 | 2011-11-15 | Hoffmann La Roche | MEDICAL INFUSION PUMP AND METHOD FOR DETERMINING THE CAUSE OF A POWER INTERRUPTION IN THE PUMP |
US8873461B2 (en) * | 2010-02-12 | 2014-10-28 | Electronics And Telecommunications Research Institute | Packet transmission/reception method and apparatus in wireless communication system |
US8306764B2 (en) * | 2010-03-22 | 2012-11-06 | T-Mobile Usa, Inc. | Battery analysis interface and measurement system |
US8525520B2 (en) * | 2010-05-26 | 2013-09-03 | Landis+Gyr Innovations, Inc. | System and method for low battery detection |
WO2011163519A2 (en) * | 2010-06-25 | 2011-12-29 | Dexcom, Inc. | Systems and methods for communicating sensor data between communication devices |
JP2012061023A (en) * | 2010-09-14 | 2012-03-29 | Angel Playing Cards Co Ltd | Card reading device and table game system |
US9203265B2 (en) * | 2010-09-21 | 2015-12-01 | Intel Corporation | Power supply |
US10231653B2 (en) | 2010-09-29 | 2019-03-19 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
US8852152B2 (en) | 2011-02-09 | 2014-10-07 | Asante Solutions, Inc. | Infusion pump systems and methods |
WO2012111002A2 (en) | 2011-02-14 | 2012-08-23 | Hoter-Ishay Idit | Rescue battery |
US10922955B2 (en) * | 2011-02-28 | 2021-02-16 | Vireo Tech, Llc | Battery interconnected smoke detector system |
CA2756489C (en) | 2011-03-03 | 2023-09-26 | J.J. Mackay Canada Limited | Parking meter with contactless payment |
US9018893B2 (en) | 2011-03-18 | 2015-04-28 | Medtronic Minimed, Inc. | Power control techniques for an electronic device |
US8564447B2 (en) | 2011-03-18 | 2013-10-22 | Medtronic Minimed, Inc. | Battery life indication techniques for an electronic device |
US9406459B2 (en) * | 2011-05-13 | 2016-08-02 | Panasonic Healthcare Holdings Co., Ltd. | Biological information measurement device |
US20130085349A1 (en) | 2011-06-21 | 2013-04-04 | Yofimeter, Llc | Analyte testing devices |
US8960498B2 (en) * | 2011-07-01 | 2015-02-24 | Gojo Industries, Inc. | Touch-free dispenser with single cell operation and battery banking |
US9127964B2 (en) | 2011-07-25 | 2015-09-08 | Ips Group Inc. | Low power vehicle detection |
US9972364B2 (en) * | 2011-10-14 | 2018-05-15 | Texas Instruments Incorporated | Method to maintain power supply voltage during brownout |
US9407098B2 (en) * | 2011-12-12 | 2016-08-02 | Apple Inc. | Determining a battery chemistry for a battery in a peripheral device |
WO2013144617A1 (en) * | 2012-03-30 | 2013-10-03 | Lifescan Scotland Limited | Battery status detection and storage method and system in medical monitoring |
US9555188B2 (en) * | 2012-04-27 | 2017-01-31 | Medtronic, Inc. | Implantable infusion device having voltage boost circuit and selection circuit to alternately connect battery with charging circuit |
WO2013163086A1 (en) * | 2012-04-27 | 2013-10-31 | Medtronic, Inc. | Charge pump sequencing for minimizing in-rush current |
US8827890B2 (en) | 2012-05-17 | 2014-09-09 | Thoratec Corporation | Touch screen interface and infrared communication system integrated into a battery |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
JP5559261B2 (en) * | 2012-07-17 | 2014-07-23 | ファナック株式会社 | Motor drive device having power storage device |
US8930028B2 (en) * | 2012-07-27 | 2015-01-06 | Roche Diagnostics Operations, Inc. | Handheld medical device functionality without battery |
US9561734B2 (en) * | 2012-07-31 | 2017-02-07 | Shimano Inc. | Bicycle power supply system |
US20140059360A1 (en) * | 2012-08-23 | 2014-02-27 | Lifescan Scotland Limited | Power supplies management in an analyte device having primary and secondary batteries |
EP2928550B1 (en) | 2012-12-07 | 2023-06-07 | Medtronic, Inc. | Minimally invasive implantable neurostimulation system |
US10130256B2 (en) | 2012-12-18 | 2018-11-20 | Sanofi-Aventis Deutschland Gmbh | Medical device with optical transfer of data and optical reading device for receiving such data |
KR20140116783A (en) * | 2013-01-07 | 2014-10-06 | 가부시키가이샤 히타치세이사쿠쇼 | Energy storage system controller |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
ES2712209T3 (en) | 2013-03-15 | 2019-05-09 | Adt Us Holdings Inc | Monitoring of security system status |
US9694192B2 (en) | 2013-10-04 | 2017-07-04 | Boston Scientific Neuromodulation Corporation | Implantable medical device with a primary and rechargeable battery |
WO2015061693A1 (en) | 2013-10-24 | 2015-04-30 | Trustees Of Boston University | Infusion system employing an infusion set for preventing mischanneling of multiple medicaments |
EP2876775B1 (en) * | 2013-11-22 | 2019-06-05 | Assa Abloy Ab | Determination of battery type |
US10278592B2 (en) | 2013-12-09 | 2019-05-07 | Samsung Electronics Co., Ltd. | Modular sensor platform |
CN105850002B (en) * | 2013-12-31 | 2020-05-12 | 三星电子株式会社 | Battery charger |
US9345883B2 (en) | 2014-02-14 | 2016-05-24 | Boston Scientific Neuromodulation Corporation | Rechargeable-battery implantable medical device having a primary battery active during a rechargeable-battery undervoltage condition |
WO2015177594A2 (en) | 2014-05-22 | 2015-11-26 | Samsung Electronics Co., Ltd. | Electrocardiogram watch clasp |
US10136857B2 (en) | 2014-05-23 | 2018-11-27 | Samsung Electronics Co., Ltd. | Adjustable wearable system having a modular sensor platform |
US9768635B2 (en) | 2014-12-15 | 2017-09-19 | Microsoft Technology Licensing, Llc | Managing battery power utilization in a mobile computing device |
US20160190844A1 (en) * | 2014-12-29 | 2016-06-30 | General Electric Company | Optimization of a battery driven ultrasound device |
WO2017007968A1 (en) | 2015-07-08 | 2017-01-12 | Trustees Of Boston University | Infusion system and components thereof |
USD813059S1 (en) | 2016-02-24 | 2018-03-20 | J.J. Mackay Canada Limited | Parking meter |
CN106933320A (en) | 2015-12-30 | 2017-07-07 | 微软技术许可有限责任公司 | The equipment with presentation of information in power-down mode |
US10691904B1 (en) | 2016-02-23 | 2020-06-23 | Ips Group Inc. | Handicapped parking placard |
US10299018B1 (en) | 2016-02-29 | 2019-05-21 | Ips Group Inc. | Pole-mounted vehicle sensor |
ES2661069B1 (en) * | 2016-09-24 | 2018-12-05 | Mateo Juan ESCARRER ALCACER | SECURITY SYSTEM FOR THE DETECTION OF PROXIMITY AND / OR PRESENCE OF PEOPLE, ANIMALS OR OBJECTS |
US10373477B1 (en) | 2016-09-28 | 2019-08-06 | Gojo Industries, Inc. | Hygiene compliance modules for dispensers, dispensers and compliance monitoring systems |
JP7175898B2 (en) | 2017-01-06 | 2022-11-21 | トラスティーズ オブ ボストン ユニバーシティ | Injection system and its components |
US11100824B2 (en) | 2017-05-05 | 2021-08-24 | Ips Group Inc. | Video display cap for parking pay station |
US10424956B2 (en) | 2017-06-19 | 2019-09-24 | Lear Corporation | Methods and systems for handling passive entry passive start (PEPS) remote controller battery self-discharge |
US10649512B2 (en) | 2017-07-25 | 2020-05-12 | Quanta Computer Inc. | High efficient battery backup system |
US10782352B2 (en) * | 2018-04-25 | 2020-09-22 | Lifescan Ip Holdings, Llc | Portable test meter with backlight battery depletion monitoring |
US10793108B2 (en) * | 2018-11-09 | 2020-10-06 | Ford Global Technologies, Llc | Bluetooth-enabled key fob |
US11922756B2 (en) | 2019-01-30 | 2024-03-05 | J.J. Mackay Canada Limited | Parking meter having touchscreen display |
CA3031936A1 (en) | 2019-01-30 | 2020-07-30 | J.J. Mackay Canada Limited | Spi keyboard module for a parking meter and a parking meter having an spi keyboard module |
US11069926B1 (en) * | 2019-02-14 | 2021-07-20 | Vcritonc Alpha, Inc. | Controlling ongoing battery system usage via parametric linear approximation |
USD911857S1 (en) | 2019-02-20 | 2021-03-02 | Ips Group Inc. | Sensor enhanced parking meter |
US11223227B1 (en) | 2019-07-03 | 2022-01-11 | Capsa Solutions Llc | Medical cart providing data continuity |
AU2020313947A1 (en) | 2019-07-16 | 2022-02-24 | Beta Bionics, Inc. | Ambulatory device and components thereof |
US11776684B2 (en) * | 2019-09-26 | 2023-10-03 | Pacesetter, Inc | Method and device for managing energy usage by a medical device |
CN110703894A (en) * | 2019-10-17 | 2020-01-17 | 苏州洋紫瑞信息科技有限公司 | Power-off-preventing shutdown module for desktop computer |
EP4072623A1 (en) * | 2019-12-13 | 2022-10-19 | Sanofi | A wireless data communication circuitry for a drug delivery device |
US11278661B2 (en) | 2020-03-10 | 2022-03-22 | Beta Bionics, Inc. | Infusion system and components thereof |
USD1011933S1 (en) | 2020-10-01 | 2024-01-23 | Ips Group Inc. | Pole-mounted sensor |
USD986084S1 (en) | 2020-10-01 | 2023-05-16 | Ips Group Inc. | Pole-mounted sensor |
USD986082S1 (en) | 2020-11-19 | 2023-05-16 | Ips Group Inc. | Sensor enhanced meter |
USD959298S1 (en) | 2020-11-19 | 2022-08-02 | Ips Group Inc. | Meter cover |
USD996237S1 (en) | 2020-11-19 | 2023-08-22 | Ips Group Inc. | Sensor enhanced meter |
USD959299S1 (en) | 2020-11-19 | 2022-08-02 | Ips Group Inc. | Meter cover |
USD959997S1 (en) | 2020-11-19 | 2022-08-09 | Ips Group Inc. | Meter cover |
CN113391208A (en) * | 2021-05-27 | 2021-09-14 | 浙江南都电源动力股份有限公司 | Needling test method of lithium battery pack |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399956A (en) * | 1992-02-03 | 1995-03-21 | Motorola, Inc. | Backup battery system for a portable electronic device |
US20060072268A1 (en) * | 2004-10-06 | 2006-04-06 | Samsung Electronics Co., Ltd. | Power supply circuit and method for stable system turn-off |
US20060128324A1 (en) * | 2004-12-14 | 2006-06-15 | Motorola, Inc. | Amplifier with varying supply voltage and input attenuation based upon supply voltage |
Family Cites Families (159)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2444064A1 (en) | 1978-12-15 | 1980-07-11 | Sodip Sa | MIXTURE OF VINYL CHLORIDE POLYMER AND POLYETHERURETHANE WITH A TERTIARY AND / OR AMMONIUM AMINE GROUP, IN PARTICULAR FOR A CONFORMED OBJECT FOR MEDICAL USE |
US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
US4781798A (en) | 1985-04-19 | 1988-11-01 | The Regents Of The University Of California | Transparent multi-oxygen sensor array and method of using same |
US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US4908523A (en) | 1988-04-04 | 1990-03-13 | Motorola, Inc. | Electronic circuit with power drain control |
US5264105A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
US5320725A (en) | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
JPH03103040A (en) * | 1989-09-12 | 1991-04-30 | Aisin Seiki Co Ltd | Power supply for electrical equipment in automobile |
WO1991004601A1 (en) * | 1989-09-20 | 1991-04-04 | Yard Jeffrey K | Automatic control circuit for backup voltage supply |
US5108819A (en) | 1990-02-14 | 1992-04-28 | Eli Lilly And Company | Thin film electrical component |
US5097122A (en) | 1990-04-16 | 1992-03-17 | Pacesetter Infusion, Ltd. | Medication infusion system having optical motion sensor to detect drive mechanism malfunction |
US5080653A (en) | 1990-04-16 | 1992-01-14 | Pacesetter Infusion, Ltd. | Infusion pump with dual position syringe locator |
US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
US5262305A (en) | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5284140A (en) | 1992-02-11 | 1994-02-08 | Eli Lilly And Company | Acrylic copolymer membranes for biosensors |
US5376070A (en) | 1992-09-29 | 1994-12-27 | Minimed Inc. | Data transfer system for an infusion pump |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US7624028B1 (en) | 1992-11-17 | 2009-11-24 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US5371687A (en) | 1992-11-20 | 1994-12-06 | Boehringer Mannheim Corporation | Glucose test data acquisition and management system |
ZA938555B (en) | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
US5299571A (en) | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
JP2959657B2 (en) | 1993-05-13 | 1999-10-06 | キヤノン株式会社 | Electronics |
US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5791344A (en) | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
US5543326A (en) | 1994-03-04 | 1996-08-06 | Heller; Adam | Biosensor including chemically modified enzymes |
US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5370622A (en) | 1994-04-28 | 1994-12-06 | Minimed Inc. | Proctective case for a medication infusion pump |
US5482473A (en) | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
JP2708374B2 (en) | 1994-07-26 | 1998-02-04 | インターナショナル・ビジネス・マシーンズ・コーポレイション | Computer battery connection device and battery switching method |
IT1271099B (en) | 1994-11-25 | 1997-05-26 | Francesco Bellifemine | DEVICE FOR THE SURVEILLANCE AND CONTROL OF AN IMPROVED FLEBOCLYSIS PLANT |
US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
US7384410B2 (en) | 1995-03-13 | 2008-06-10 | Cardinal Health 303, Inc. | System and method for managing patient care |
US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
JP2723839B2 (en) * | 1995-06-27 | 1998-03-09 | 静岡日本電気株式会社 | Battery backup device |
US5750926A (en) | 1995-08-16 | 1998-05-12 | Alfred E. Mann Foundation For Scientific Research | Hermetically sealed electrical feedthrough for use with implantable electronic devices |
US5972199A (en) | 1995-10-11 | 1999-10-26 | E. Heller & Company | Electrochemical analyte sensors using thermostable peroxidase |
US6689265B2 (en) | 1995-10-11 | 2004-02-10 | Therasense, Inc. | Electrochemical analyte sensors using thermostable soybean peroxidase |
US5665222A (en) | 1995-10-11 | 1997-09-09 | E. Heller & Company | Soybean peroxidase electrochemical sensor |
US5717308A (en) | 1995-10-20 | 1998-02-10 | Fuji Photo Film Co., Ltd. | Electric-supply equipment for camera |
US5684384A (en) * | 1995-10-31 | 1997-11-04 | Motorola, Inc. | Apparatus and method for discharging and charging a multiple battery arrangement |
JPH09294330A (en) * | 1996-04-26 | 1997-11-11 | Hitachi Ltd | Power circuit of information communication terminal |
US6050940A (en) * | 1996-06-17 | 2000-04-18 | Cybernet Systems Corporation | General-purpose medical instrumentation |
US6043437A (en) | 1996-12-20 | 2000-03-28 | Alfred E. Mann Foundation | Alumina insulation for coating implantable components and other microminiature devices |
WO1998035225A1 (en) | 1997-02-06 | 1998-08-13 | E. Heller & Company | Small volume in vitro analyte sensor |
US5779665A (en) | 1997-05-08 | 1998-07-14 | Minimed Inc. | Transdermal introducer assembly |
US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
US5835366A (en) * | 1997-06-24 | 1998-11-10 | Telxon Corporation | Secondary battery boost circuit |
US6071391A (en) | 1997-09-12 | 2000-06-06 | Nok Corporation | Enzyme electrode structure |
US5999849A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Low power rectifier circuit for implantable medical device |
US6259937B1 (en) | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US5999848A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Daisy chainable sensors and stimulators for implantation in living tissue |
US5917346A (en) | 1997-09-12 | 1999-06-29 | Alfred E. Mann Foundation | Low power current to frequency converter circuit for use in implantable sensors |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6081736A (en) | 1997-10-20 | 2000-06-27 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems adapted for long term use |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
JPH11149420A (en) * | 1997-11-14 | 1999-06-02 | Toshiba Corp | Portable information equipment and power source managing method |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6169387B1 (en) * | 1997-12-22 | 2001-01-02 | Lifecor, Inc. | Battery management apparatus for portable electronic devices |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
EP1061972A1 (en) | 1998-03-16 | 2000-12-27 | Medtronic, Inc. | Hemostatic system and components for extracorporeal circuit |
US5904708A (en) | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6294281B1 (en) | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
CA2666429A1 (en) | 1998-10-08 | 2000-04-13 | Medtronic Minimed, Inc. | Telemetered characteristic monitor system |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6561978B1 (en) | 1999-02-12 | 2003-05-13 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
US6560741B1 (en) | 1999-02-24 | 2003-05-06 | Datastrip (Iom) Limited | Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same |
US6475750B1 (en) | 1999-05-11 | 2002-11-05 | M-Biotech, Inc. | Glucose biosensor |
US6752787B1 (en) | 1999-06-08 | 2004-06-22 | Medtronic Minimed, Inc., | Cost-sensitive application infusion device |
US6654625B1 (en) | 1999-06-18 | 2003-11-25 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
US7247138B2 (en) | 1999-07-01 | 2007-07-24 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6804558B2 (en) | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
CA2314517A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
US6514460B1 (en) | 1999-07-28 | 2003-02-04 | Abbott Laboratories | Luminous glucose monitoring device |
US20010022472A1 (en) * | 1999-09-30 | 2001-09-20 | George Codina | Method and apparatus for providing uninterrupted power during transitions between a power source and a standby generator using capacitor supplied voltage |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6605201B1 (en) | 1999-11-15 | 2003-08-12 | Therasense, Inc. | Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith |
US6873268B2 (en) | 2000-01-21 | 2005-03-29 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US20030060765A1 (en) | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
AU2001243285A1 (en) | 2000-03-02 | 2001-09-12 | Donnelly Corporation | Video mirror systems incorporating an accessory module |
US6478440B1 (en) | 2000-03-10 | 2002-11-12 | S.C. Johnson & Son, Inc. | Night light air freshener |
US7025425B2 (en) | 2000-03-29 | 2006-04-11 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
US6623501B2 (en) | 2000-04-05 | 2003-09-23 | Therasense, Inc. | Reusable ceramic skin-piercing device |
AU2001263022A1 (en) | 2000-05-12 | 2001-11-26 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
WO2002017210A2 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
JP2002101574A (en) * | 2000-09-22 | 2002-04-05 | Sony Corp | Power supply circuit |
CA2431420C (en) * | 2000-12-21 | 2011-10-11 | Insulet Corporation | Medical apparatus remote control and method |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6676816B2 (en) | 2001-05-11 | 2004-01-13 | Therasense, Inc. | Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
US6671554B2 (en) | 2001-09-07 | 2003-12-30 | Medtronic Minimed, Inc. | Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same |
US7025760B2 (en) | 2001-09-07 | 2006-04-11 | Medtronic Minimed, Inc. | Method and system for non-vascular sensor implantation |
US7052591B2 (en) | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
US7399277B2 (en) | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20030140929A1 (en) | 2002-01-29 | 2003-07-31 | Wilkes Gordon J. | Infusion therapy bar coding system and method |
US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
US8512276B2 (en) | 2002-07-24 | 2013-08-20 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7278983B2 (en) | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US20050197553A1 (en) | 2002-07-30 | 2005-09-08 | Colleen Cooper | Patient management of diabetes treatment |
US7162289B2 (en) | 2002-09-27 | 2007-01-09 | Medtronic Minimed, Inc. | Method and apparatus for enhancing the integrity of an implantable sensor device |
US7736309B2 (en) | 2002-09-27 | 2010-06-15 | Medtronic Minimed, Inc. | Implantable sensor method and system |
US7138330B2 (en) | 2002-09-27 | 2006-11-21 | Medtronic Minimed, Inc. | High reliability multilayer circuit substrates and methods for their formation |
US20040061232A1 (en) | 2002-09-27 | 2004-04-01 | Medtronic Minimed, Inc. | Multilayer substrate |
DE60336834D1 (en) | 2002-10-09 | 2011-06-01 | Abbott Diabetes Care Inc | FUEL FEEDING DEVICE, SYSTEM AND METHOD |
US20040074785A1 (en) | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
US6931328B2 (en) | 2002-11-08 | 2005-08-16 | Optiscan Biomedical Corp. | Analyte detection system with software download capabilities |
GB2395373A (en) | 2002-11-18 | 2004-05-19 | Nec Technologies | Backup battery for uninterrupted power supply |
US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
TW200413887A (en) * | 2003-01-20 | 2004-08-01 | Htc Corp | Automatic turn-on portable device by detecting a battery condition |
KR100521855B1 (en) | 2003-01-30 | 2005-10-14 | 최수봉 | Control method of insulin pump by bluetooth protocol |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US7269199B2 (en) | 2003-08-28 | 2007-09-11 | Lenovo (Singapore) Pte. Ltd. | Apparatus and method employing dynamic hop sequence adjustment in FHSS networks |
US20070106133A1 (en) | 2003-11-18 | 2007-05-10 | Satchwell Bruce R | Monitoring of vital signs and performance levels |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
EP2239566B1 (en) | 2003-12-05 | 2014-04-23 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US20050137573A1 (en) | 2003-12-19 | 2005-06-23 | Animas Corporation | System, method, and communication hub for controlling external infusion device |
US7201977B2 (en) | 2004-03-23 | 2007-04-10 | Seagate Technology Llc | Anti-ferromagnetically coupled granular-continuous magnetic recording media |
US20050273080A1 (en) | 2004-05-20 | 2005-12-08 | Paul Patrick J | Methods and systems for providing an interface between an ambulatory medical device and a display device |
US20070100222A1 (en) | 2004-06-14 | 2007-05-03 | Metronic Minimed, Inc. | Analyte sensing apparatus for hospital use |
US7344500B2 (en) | 2004-07-27 | 2008-03-18 | Medtronic Minimed, Inc. | Sensing system with auxiliary display |
US20060049957A1 (en) | 2004-08-13 | 2006-03-09 | Surgenor Timothy R | Biological interface systems with controlled device selector and related methods |
CN101156171A (en) | 2004-12-07 | 2008-04-02 | 瑞利夫公司 | Security and storage system and method |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US20060173260A1 (en) | 2005-01-31 | 2006-08-03 | Gmms Ltd | System, device and method for diabetes treatment and monitoring |
US7514040B2 (en) | 2005-02-14 | 2009-04-07 | Taidoc Technology Corporation | Intelligent biosensing meter |
US7281811B2 (en) | 2005-03-31 | 2007-10-16 | S. C. Johnson & Son, Inc. | Multi-clarity lenses |
US20060259676A1 (en) | 2005-05-13 | 2006-11-16 | North American Technology Services, Inc. | Blood glucose meter/modem interface arrangement |
US7181350B2 (en) | 2005-05-13 | 2007-02-20 | North America Technology Services, Inc. | Blood glucose meter/modem interface arrangement |
EP1736772B1 (en) | 2005-06-22 | 2016-05-18 | F.Hoffmann-La Roche Ag | Test device with test element storage device |
US20070004969A1 (en) | 2005-06-29 | 2007-01-04 | Microsoft Corporation | Health monitor |
US20070115650A1 (en) | 2005-08-12 | 2007-05-24 | Howard Cohan | Illuminated exhibitor |
US20090227855A1 (en) | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
US20070093786A1 (en) | 2005-08-16 | 2007-04-26 | Medtronic Minimed, Inc. | Watch controller for a medical device |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8018424B2 (en) | 2006-10-19 | 2011-09-13 | Au Optronics Corporation | Backlight device with zone control |
US20080294024A1 (en) | 2007-05-24 | 2008-11-27 | Cosentino Daniel L | Glucose meter system and monitor |
US20090034958A1 (en) | 2007-07-30 | 2009-02-05 | Karl Allen Dierenbach | Gaze Attracting System for Image Capturing |
WO2009038798A1 (en) | 2007-09-21 | 2009-03-26 | Charm Sciences, Inc. | Assay reader insert and method of maintaining a reader |
US20090303477A1 (en) | 2008-06-10 | 2009-12-10 | Burd John F | Reagent-Less Test Strip System for Analyte Measurement and Method of Use |
-
2006
- 2006-06-06 US US11/447,637 patent/US7737581B2/en active Active
-
2007
- 2007-06-05 CA CA2654193A patent/CA2654193C/en active Active
- 2007-06-05 WO PCT/US2007/013249 patent/WO2007145951A2/en active Application Filing
- 2007-06-05 CA CA3057662A patent/CA3057662A1/en active Pending
- 2007-06-05 EP EP07795760.3A patent/EP2033068B1/en active Active
- 2007-06-05 JP JP2009514337A patent/JP5264715B2/en not_active Expired - Fee Related
-
2010
- 2010-04-27 US US12/768,424 patent/US8106534B2/en not_active Expired - Fee Related
-
2011
- 2011-12-20 US US13/332,249 patent/US20120091813A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399956A (en) * | 1992-02-03 | 1995-03-21 | Motorola, Inc. | Backup battery system for a portable electronic device |
US20060072268A1 (en) * | 2004-10-06 | 2006-04-06 | Samsung Electronics Co., Ltd. | Power supply circuit and method for stable system turn-off |
US20060128324A1 (en) * | 2004-12-14 | 2006-06-15 | Motorola, Inc. | Amplifier with varying supply voltage and input attenuation based upon supply voltage |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11580918B2 (en) | 2008-05-02 | 2023-02-14 | Tandem Diabetes Care, Inc. | Display for pump |
US11488549B2 (en) | 2008-05-02 | 2022-11-01 | Tandem Diabetes Care, Inc. | Display for pump |
US9101714B2 (en) | 2010-03-25 | 2015-08-11 | Seiko Epson Corporation | Fluid injection system |
US9242569B2 (en) | 2011-07-15 | 2016-01-26 | Mitsubishi Electric Corporation | Vehicle charge system and vehicle charge method |
US9146595B2 (en) * | 2011-08-05 | 2015-09-29 | Qualcomm Incorporated | Systems and methods for remotely monitoring or controlling a battery |
US20130148283A1 (en) * | 2011-08-05 | 2013-06-13 | Qualcomm Incorporated | Systems and methods for remotely monitoring or controlling a battery |
US20140139114A1 (en) * | 2011-11-21 | 2014-05-22 | Richard Jeff Garcia | Method of Adjusting Brightness By Desired Run Time |
US8853951B2 (en) * | 2011-11-21 | 2014-10-07 | Janlincia Llc | Method of adjusting brightness by desired run time |
US9976551B2 (en) | 2012-12-07 | 2018-05-22 | Smiths Medical Asd, Inc. | Syringe characterization |
US11776689B2 (en) | 2013-03-15 | 2023-10-03 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
US11152115B2 (en) | 2013-03-15 | 2021-10-19 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
US11383027B2 (en) | 2013-12-26 | 2022-07-12 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US9737656B2 (en) | 2013-12-26 | 2017-08-22 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US10213547B2 (en) | 2013-12-26 | 2019-02-26 | Tandem Diabetes Care, Inc. | Safety processor for a drug delivery device |
US11911590B2 (en) | 2013-12-26 | 2024-02-27 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US10478551B2 (en) | 2013-12-26 | 2019-11-19 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US9486571B2 (en) | 2013-12-26 | 2016-11-08 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
US10806851B2 (en) | 2013-12-26 | 2020-10-20 | Tandem Diabetes Care, Inc. | Wireless control of a drug delivery device |
US10918785B2 (en) | 2013-12-26 | 2021-02-16 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
JP2020110605A (en) * | 2013-12-31 | 2020-07-27 | アッヴィ・インコーポレイテッド | Pump, motor, and assembly for delivery of beneficial agent |
US20150235058A1 (en) * | 2014-02-20 | 2015-08-20 | Samsung Electronics Co., Ltd. | Electronic apparatus and protecting method thereof |
WO2017095962A1 (en) * | 2015-11-30 | 2017-06-08 | Airwire Technologies | A backup circuitry for providing power |
US20170328197A1 (en) * | 2016-05-13 | 2017-11-16 | Ningbo Wanyou Deepwater Energy Science & Technolog Co.,Ltd. | Data Logger, Manufacturing Method Thereof and Real-time Measurement System Thereof |
US10357603B2 (en) | 2017-01-11 | 2019-07-23 | Tandem Diabetes Care, Inc. | Electromagnetic signal-based infusion pump control |
WO2018175030A1 (en) * | 2017-03-22 | 2018-09-27 | Intel Corporation | Mechanism to extend the peak power capability of a mobile platform |
US10431976B2 (en) | 2017-03-22 | 2019-10-01 | Intel Corporation | Mechanism to extend the peak power capability of a mobile platform |
US11666704B2 (en) | 2017-07-18 | 2023-06-06 | Becton, Dickinson And Company | Administration system, delivery device, and notification device for communicating status of a medical device |
US10790682B2 (en) | 2018-03-30 | 2020-09-29 | Intel Corporation | Hybrid power boost charging with peak power protection |
US11464901B2 (en) * | 2019-02-19 | 2022-10-11 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US10888655B2 (en) * | 2019-02-19 | 2021-01-12 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US20230033867A1 (en) * | 2019-02-19 | 2023-02-02 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
US11305057B2 (en) | 2019-03-26 | 2022-04-19 | Tandem Diabetes Care, Inc. | Method and system of operating an infusion pump with a remote control device |
Also Published As
Publication number | Publication date |
---|---|
CA3057662A1 (en) | 2007-12-21 |
US8106534B2 (en) | 2012-01-31 |
US20100201196A1 (en) | 2010-08-12 |
WO2007145951A2 (en) | 2007-12-21 |
WO2007145951A3 (en) | 2008-07-17 |
US20070040449A1 (en) | 2007-02-22 |
JP5264715B2 (en) | 2013-08-14 |
CA2654193A1 (en) | 2007-12-21 |
CA2654193C (en) | 2019-11-26 |
JP2009540783A (en) | 2009-11-19 |
US7737581B2 (en) | 2010-06-15 |
EP2033068A2 (en) | 2009-03-11 |
EP2033068B1 (en) | 2018-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8106534B2 (en) | Method and apparatus for predicting end of battery life | |
EP1924307B1 (en) | Hand-held controller device for an infusion pump | |
US8663201B2 (en) | Infusion device | |
US20070060870A1 (en) | Controller device for an infusion pump | |
US11253647B2 (en) | Modular external infusion device | |
US20070093786A1 (en) | Watch controller for a medical device | |
US20070100222A1 (en) | Analyte sensing apparatus for hospital use | |
US20190070361A1 (en) | Activity Sensing Techniques for an Infusion Pump System | |
US20120227737A1 (en) | Analyte sensor and method of using the same | |
US11109316B2 (en) | Methods of wireless communication in an infusion pump system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SPURLIN, JON;GABLENZ, JOHN;MEHTA, KAEZAD J.;SIGNING DATES FROM 20060724 TO 20060801;REEL/FRAME:027422/0334 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |